Abstract
Pharmaceuticals and personal care products present potential risks to human health and the environment. In particular, wastewater treatment plants often detect emerging pollutants that disrupt biological treatment. The activated sludge process is a traditional biological method with a lower capital cost and limited operating requirements than more advanced treatment methods. In addition, the membrane bioreactor combines a membrane module and a bioreactor, widely used as an advanced method for treating pharmaceutical wastewater with good pollution performance. Indeed, the fouling of the membrane remains a major problem in this process. In addition, anaerobic membrane bioreactors can treat complex pharmaceutical waste while recovering energy and producing nutrient-rich wastewater for irrigation. Wastewater characterizations have shown that wastewater’s high organic matter content facilitates the selection of low-cost, low-nutrient, low-surface-area, and effective anaerobic methods for drug degradation and reduces pollution. However, to improve the biological treatment, researchers have turned to hybrid processes in which all physical, chemical, and biological treatment methods are integrated to remove various emerging contaminants effectively. Hybrid systems can generate bioenergy, which helps reduce the operating costs of the pharmaceutical waste treatment system. To find the most effective treatment technique for our research, this work lists the different biological treatment techniques cited in the literature, such as activated sludge, membrane bioreactor, anaerobic treatment, and hybrid treatment, combining physicochemical and biological techniques.
Similar content being viewed by others
Avoid common mistakes on your manuscript.
Introduction
Over the past decades, drug research has made tremendous strides in ensuring a safe and healthy life. However, these pharmaceutical components have become a new environmental threat (Khan et al. 2021a, b, c; Polianciuc et al. 2020; Peña et al. (2021) mentioned that pharmaceutical discharges to the natural environment accumulate to damage aquatic ecosystems and cause public health problems.
In this context, our research aims to improve the biological treatment of wastewater produced by the pharmaceutical industry, so we propose this work as a literature review on recent work in this field to have a clear idea on our intervention.
Detailed studies by Archer et al. (2021) and Devault et al. (2021) have characterized compounds in the environment, such as pharmaceuticals, personal care products, endocrine disruptors, hormones, and antibiotics, to select an effective and efficient treatment process. Khan et al. (2021a, b, c) and Mukherjee et al. (2021) mentioned a need to monitor and evaluate the environmental risks caused by pharmaceuticals at wastewater treatment plants. This allows the development of treatment technologies to minimize negative environmental impacts (Simon et al. 2021). In addition, the industrial processes used for drug production condition the nature of liquid and solid discharges, which have non-negligible impacts on the environment, public health, and especially on the operation of wastewater treatment plants (Bilal et al. 2020; Wang et al. 2020a, b).
Antibiotics have a specific action with killing power on microorganisms at therapeutic doses (Kortright et al. 2019). Work that addresses antibiotic detection in the environment is growing (Ayankojo et al. 2020). The presence of antibiotics in the aquatic environment poses two problems: the potential toxicity of these compounds to aquatic organisms and humans via drinking water and the possibility of developing resistance in pathogenic bacteria (Kovalakova et al. 2020; Szymańska et al. 2019).
Traditionally, pharmaceutical wastewater treatment can be divided into primary, secondary, and tertiary. Primary treatment is chemical or physicochemical (Agrawal et al. 2020; Wang and Chen 2022), secondary treatment is mainly based on biological processes (Han et al. 2020; Zhu et al. 2021), and tertiary treatment is composed of advanced oxidation processes (Verma and Haritash 2020; Wang and Zhuan 2020).
Wastewater treatment shops (WWTPs) are frequently considered as one of the main pathways for the preface of PhACs into the Submarine terrain via treated water or into the terrestrial terrain by disposal of the sewage sludge/ biosolids in tips (Nguyen et al. 2021). Still, WWTPs also serve as a hedge to control the discharge of these PhACs into the terrain (Rueda-Márquez et al. 2020). There are multitudinous ways WWTPs can impact the metamorphosis and junk of these composites (Nguyen et al. 2021). Biological processes are generally the most usable approaches in WWTPs. They have been frequently reported to have an important impact on the junking of numerous PhACs in WWTPs, similar to conventional activated sludge treatment (CAS) (Kołecka et al. 2019); membrane bioreactors (MBRs) (Carolin et al. 2021), moving bed biofilm reactors (MBBRs) (Song et al. 2020), and constructed washes (Button et al. 2019).
Several ultramodern anaerobictechnologies have shown their capabilities in the effective treatment of medicinal, including anaerobic membrane bioreactor (AnMBR) (Huang et al. 2018), up-flow anaerobic sludge mask (UASB) (Mareai et al. 2020), anaerobic sequencing batch reactor (AnSBR) (Karanan et al. 2020), moving bed biofilm reactor (MBBR) (Ooi et al. 2018), and other mongrel technologies. In addition, the development of AnMBR provides a promising result because AnMBR is coupled together with the anaerobic process and the membrane filtration to produce a solid-free effluent by the complete retention of biomass (Shi et al. 2017). AnMBR also contributes to energy generation because it can produce methane from exercising a lot of organics in wastewaters. Likewise, footmark and space can be reduced while producing an effluent of largely bettered quality (Anjum et al. 2021).
Lu et al. (2020) and Pan et al. (2021) mentioned that biological remediation has an advantage over other chemical methods due to the by-products generated by physicochemical and advanced oxidation treatments that render water toxic. A bioremediation technology such as aerobic, anaerobic, or membrane bioreactor aims to treat antibiotics through microbial transformation, making the water less toxic and more stable than its original polluted state (Shah and Shah 2020).
Dutta and Bhattacharjee (2022) and Kumar et al. (2022) mentioned that biological and physicochemical treatment processes have advantages and disadvantages. Biological treatment does not effectively mineralize pharmaceutical compounds (Jamil et al. 2021). These can cause toxicity to the bacterial community of the biological process (Tiwari et al. 2020). In the case of advanced treatments, most processes are very energy-intensive and expensive (Taoufik et al. 2021). Tiwari et al. (2020) mentioned that the use of chemicals and high pH in the advanced oxidation process places an additional burden on the economics of the process.
Therefore, attempts by Çifçi and Meriç (2022) and Li et al. (2022) have been made to combine biological and physicochemical treatments to provide an efficient wastewater treatment system and improve the process economics. For example, hybrid treatment processes, including anaerobic and aerobic treatment, have been developed by Tiwari et al. (2020), and membrane bioreactors combined with advanced oxidation process (AOP) and reverse osmosis are used due to their ease of use and superior performance (Priyanka et al. 2021). It is, of course, recognized that the scientific research must entrust the choice of the appropriate technique that effectively meets the requirements of the regulatory standards.
This study aims to present the current status of biological treatment processes for pharmaceutical wastewater and their effectiveness for the degradation and removal of various pharmaceuticals. We first present the sources of pharmaceutical products that generate emerging micropollutants. We analyze their effect on wastewater treatment plants and receiving environments. We present a review of the various research works on current treatments to eliminate toxic products, and finally, we end with synthesis and a conclusion.
The origins of pharmaceuticals in wastewater
Pharmaceuticals and personal care products pose potential risks to human health rather than to the environment (Chami et al. 2021; Trouillard et al. 2021). Martínez et al. (2021) and Tiwari et al. (2020) noted that these pollutants are ubiquitous in the environment from different sources.
Drug residues have been observed in all aspects of life (Guo et al. 2021). Their existence and fate are generally dependent on the source, route of entry, and environmental matrix (Khan et al. 2020a, b; Rasheed et al. 2020).
At the inlet of wastewater treatment plants, Kar et al. (2020) and Rasheed et al. (2020) detected several environmental pollutants, including anti-inflammatory drugs, analgesics, plasticizers, preservatives, anti-epileptics, hormones, solar stimulants, and heavy metals on a global-scale Pain medications and bactericides are primarily found in aquatic organisms due to their widespread consumption (Gernigon et al. 2020; Villemin et al. 2021). Sulfonamides and tetracyclines are commonly used antibiotics that are highly stable and permeable in the environment (Landecker 2021; Nys and Vété 2021). Similarly, Bilal et al. (2020) and Zainab et al. (2020) mentioned that ibuprofen is one of the most used drugs, and it is considered among the toxic pollutants in the ecosystem. Furthermore, Palma et al. (2020) and Vass et al. (2020) reported that pharmaceuticals are classified into seven distinct groups based on their applications, such as X-ray contrast agents, analgesics, antibiotics, cytostatics, anticonvulsants, β-blockers, and lipid regulators (Santos et al. 2020), in addition steroids, synthetic hormones, fragrances, lipid regulators, analgesics, shampoos, and cosmetics (Chaturvedi et al. 2021; Van et al. 2021).
Hospitals and pharmaceutical plants are the main sources of pharmaceutical products in the environment, especially during the COVID-19 pandemic (Khan et al. 2021a, b, c). Other secondary sources also exist, such as discarded medicines and mismanagement of pharmaceuticals (Bu et al. 2020; Kar et al. 2020). Indeed, thousands of pharmaceuticals are traceable in the environment, so various parameters such as consumption pattern, ecotoxicity, risk, biodegradation, and processing difficulty are prioritized (Kairigo et al. 2020; Khan et al. 2020a, b; Kroon et al. 2020). Once they leave the manufacturing center and reach the retail market, the environmental exposure pathways become too fragmented to track and analyze. Dey et al. (2019) found that humans use various consumer products, including pharmaceuticals, so everyone is an active contributor. Products such as detergents, household cleaners, disinfectants, fungicides, and cosmetics are all active sources of pharmaceuticals and can enter the aquatic system directly (Guo et al. 2021; Lindberg et al. 2021).
The processing of pharmaceuticals does not allow the reduction of emerging compounds (Bilal et al. 2020; Pereira et al. 2020). Indeed, the drug is released into the environment as a parent compound, metabolite, and conversion product, causing contamination of the surface, marine, and groundwater (Santos et al. 2020). This causes resistance in several pathogenic bacterial strains (He et al. 2021). Overexposure to antibiotics can alter microbial diversity and harm the upper food chain (Dey et al. 2019).
Table 1 illustrates the consumption in the UK of the top 20 drugs used for different diseases with their PEC and PNEC ratios. PEC represents the concentration of the substance in the environment, and PNEC represents the predicted no-effect concentration.
Impacts of pharmaceuticals
Pharmaceutical and personal care products PPCP are used worldwide (Niemi et al. 2020; Galani et al. 2021). They are released into the ecosystem in various ways, causing potential threats to different parts of the environment (García-Fernández et al. 2021; Schwartz et al. 2021). In particular, active pharmaceutical PhAC compounds can affect aquatic organisms, even when they occur at low concentrations (Nguyen et al. 2021). In addition, new regulations aimed at preserving water quality have increased the need to monitor and reduce certain PhACs at wastewater treatment plants (Liang et al. 2021; Usman et al. 2020,).
Active pharmaceutical compounds have been used to address many diseases, including life-threatening diseases such as a concert, diabetes, influenza, COVID-19, and goiters (Chaubey et al. 2021; Varnai et al. 2021). Porika et al. (2021) and Reichert et al. (2020) reported that many micropollutants had been found in terrestrial and aquatic environments over the past 20 years. These micropollutants can lead to multi-drug resistance in bacteria which is harmful to human health. Thus, Chaturvedi et al. (2021) and Varnai et al. (2021) have indicated that sustained release of antibiotics in aquatic ecosystems and soils is among the major priorities.
Humans are most likely to be exposed to pharmaceutical residues and personal care in their daily lives through contaminated air, water, or soil (Ferreira et al. 2020; Keerthanan et al. 2021). Human contact with pharmaceutical waste causes human health damage such as allergies, diseases, and tumors (Dehkordi et al. 2021; Oliveira et al. 2020). In a survey conducted in Australia by Kroon et al. (2020), many antibiotics, such as tetracycline, erythromycin, and sulfonamides, were found in wastewater. Ricky and Shanthakumar (2022) and Wang et al. (2021a, b, c) mentioned that one of the reasons for this exposure is their bioaccumulation and entry into the food chain via sewage plants and agriculture.
Most ecotoxicological studies of PPCPs exposure to non-target organisms are from acute toxicity data (Ghahari et al. 2021; Liang et al. 2021). Among the negative impacts of pharmaceuticals on aquatic communities, Bio and Nunes (2020) and Khalil et al. (2020) cited the failure of natural reproduction and the extinction of some living things. Fish are very sensitive to pollution because they are linked to the environment, where these pollutants are most mobile (Beiras 2021). For example, diclofenac and gemfibrozil are expected to have a direct negative effect on fish organs. On the other hand, algae are phototrophic organisms that regulate the cycle of energy and nutrients in the water. Therefore, their activities are important for the survival of the entire ecosystem (Hussain et al. 2021; Piwowar and Harasym 2020). According to Harshkova et al. (2021) and Majewska et al. (2021) in the presence of carbamazepine and diclofenac, algae’s chloroplasts are severely damaged. Long-term exposure to sulfamethoxazole can cause chronic algal toxicity and interfere with photosynthesis (Mojiri et al. 2022). In addition, hormones tend to unbalance the endocrine system in aqueous environments, thereby disrupting the homeostasis of non-target organisms (Sicard et al. 2020). Some will inhibit the activity of natural hormones, while others will cause physiological changes and even induction of female characteristics in male fish (Dey et al. 2019; Tiwari et al. 2020).
Antibiotics cause multigenerational transformations in the entire biological community (Juma et al. 2020; Liu et al. 2020a, b). Kovalakova et al. (2020) and Ricky et Shanthakumar (2022) have shown that biocides are considered harmful emerging pollutants. It lasts longer in the environment. Antibiotics are often detected at low concentrations in seawater, groundwater, surface water, and even drinking water (Chaturvedi et al. 2021; Sahani et al. 2022). Parent antibiotic molecules or their metabolites are released into the aquatic environment, resulting in virtual or long-lasting ecological effects and contamination and the emergence of antibiotic resistance (Harrower et al. 2021; Rico et al. 2021).
Liu et al. (2020a, b) and Shahriar et al. (2021) observed that irrigation with wastewater could lead to a greater accumulation of PPCPs in the soil than in groundwater. PPCPs, such as estrone, naproxen, triclosan, ibuprofen, and clofibric acid, can contaminate groundwater due to their high leaching properties (Liu et al. 2020a, b; Tosun et al. 2020).
Impacts of pharmaceuticals on wastewater treatment plants
Removal of pharmaceutical pollutants is limited due to their high biological toxicity (Vargas-Berrones et al. 2020; Vasilachi et al. 2021). They even promote ARG antibiotic-resistant bacteria and genes (Fu et al.2020; Salazar et al. 2020). The presence of antibiotics and other drugs in the environment has become a growing public concern that requires reliable management of treatment of these pollutants, as reported by (Jose et al. 2020; Zhang et al. 2022).
Indeed, Yadav et al. (2020) and Zhou et al. (2021) have shown that incomplete degradation of antibiotics would lead to residual compounds in wastewater treatment plants which strongly influence the performance of treatment plants. The latter hinders the depollution processes because of the phosphorus compounds that have a considerable impact on the functioning of the treatment plants (Chen et al. 2020). The need then became urgent to purify wastewater containing antibiotics effectively. To this end, denitrification has been widely used to treat wastewater from pharmaceutical discharges with high nitrate (Robson et al. 2020; Guan et al. 2022). This process is considered sensitive to various environmental factors, such as carbon sources, heavy metals, and antibiotics. Various antibiotics can have a significant effect on denitrifying microorganisms and denitrification rates, such as sulfamethoxazole and tetracycline (Osińska et al. 2020; Wang et al. 2020a, b), including microbial community performance, diversity and dynamics, and dominant bacteria (Fan et al. 2020; Zhang et al. 2022). Shu and Liang (2022) and Wang et al. (2020a, b) found that the high concentration of tetracycline affects its community structure and abundance and can inhibit bacterial growth and reproduction of bacterial ribosomal units.
Gurmessa et al. (2020) and Xiao et al. (2021) mentioned that the efficiency of anaerobic digestion could be reduced by the presence of antibiotics and their residues, which can inhibit the microbial community and activity. The abundance of ARG-carrying bacteria increased with the addition of antibiotics. This limits the overall system efficiency improvement and leads to the spread of GRAs (Cheng et al. 2021).
The production of biomethane from macromolecular organic carbon involves processing a variety of microorganisms, primarily fermenting bacteria and methanogenic archaea (Nozhevnikova et al. 2020; Tao et al. 2020). Microorganisms convert complex organic matter into methane through anaerobic digestion, which is the primary means of mineralization of organic matter (Xie et al. 2020; Azizan et al. 2021). Some antibiotics that affect anaerobic fermentation, such as macrolides and tetracyclines, are protein synthesis inhibitors in bacteria and inhibit bacterial growth (Kong and Yang 2021). For this reason, antibiotics have inhibitory effects on bacteria with hydrolytic and acidifying functions (Liu et al. 2021; Xiao et al. 2021). Finally, Cheng et al. (2021) and Zarei-Baygi et al. (2020) mentioned that sulfonamide (SM) antibiotic increases membrane fouling in the anaerobic membrane bioreactor process.
Moroccan regulations on pharmaceutical waste
Morocco has implemented a series of major institutional and economic reforms to stabilize the country’s policy and help it withstand the effects of climate change (Pouya et al. 2021; Karim et al. 2021). Indeed, Morocco is now committed to sustainable development and considers it the main development option at the national level (Barakat et al. 2020) and the continuous improvement of citizens to acquire a better quality of life (Khetrapal and Bhatia 2020). Furthermore, Jain et al. (2022) and Johansen et al. (2022) mentioned that sustainable development has recently gained much interest and priority in protecting and maintaining natural balances disturbed by a wide range of human activities.
Morocco is particularly sensitive and aware of the depletion of its natural resources due to human factors. Therefore, it has begun to address this through various sectors, including those known to directly impact the environment and health (Niemi et al. 2020; Ghahari et al. 2021). To achieve sustainable development, it is necessary to protect natural resources and make rational use of them. In addition, natural resources must be used rationally and recycled to the maximum (Dahchour et al. 2021; Makan et al. 2021). For example, the former water law commits all cities to collect and treat wastewater (El Hmaidi et al. 2021; Oualkacha et al. 2022). In particular, it is necessary to formulate strict urban wastewater treatment standards following the receiving environment and discharge standards. In addition, measures are needed to prevent pollution of surface and groundwater (Touzani et al. 2020; Ouakkas et al. 2022). The new law enacted in 2016 provided for the reuse of wastewater and sewage sludge and stipulated that treated wastewater must meet quality standards (Mansir et al. 2021; Belazreg et al. 2021).
In Morocco, the standard for irrigation water is determined by the Directorate of Equipment and the Directorate of Land Use, Urban Planning, Habitat, and Environment to establish quality standards for irrigation water (Oertlé et al. 2020).
Hdidou et al. (2022) and Slamini et al. (2022) indicated that Morocco faces a growing water scarcity challenge. Abou-tammame et al. (2022) discussed the reuse of treated wastewater as an important opportunity to close the gap between water demand and need in Morocco. If properly disposed of and recycled, it can cover more than 13% of total water consumption. In the circular economy paradigm, the reuse of treated wastewater in agriculture can solve water shortages and pollution problems (Gulzar et al. 2022). Wastewater is now considered a cheap, renewable, non-conventional resource rather than pollution (Abdouni et al. 2021). Therefore, these resources can supplement or replace freshwater in areas that do not require quality water for agricultural irrigation (Gulzar et al. 2022).
Morocco has made significant progress in municipal wastewater treatment under the National Sanitation Plan (Hdidou et al. 2022). However, rural health facilities have experienced serious delays. The 2006 National Health Plan aims to reduce the overall treatment rate from 8 to 60% by 2020. The national plan also calls for the number of wastewater treatment plants to increase to 330 by 2030, of which 145 were commissioned in 2015. This opens up new opportunities for water reuse (Ait-Mouheb et al. 2020; Oertlé et al. 2020). The National Water Plan (PNE) published in 2009 predicted that the total amount of reusable wastewater in 2030 will vary around 935 mm3 for a reuse rate of 31% of the same year 2030.
Morocco’s approach is based on existing legislation, guided by different environmental legal texts, and supported by different national plans related to different sectors. This opens the way for the private sector to contribute to public–private projects to achieve investment and efficiency goals (Dahchour et al. 2021).
Biological treatment techniques for pharmaceutical waste
For each treatment step, wastewater can be treated in different unitary processes. The unit operations that can be used at different processing levels are shown in Fig. 1.
Figure 1 shows the different treatment techniques for pharmaceutical waste, namely primary treatment which includes flotation system, primary sedimentation tank, neutralization tank, equalization tank, in addition, secondary treatment which consists of biological and physicochemical treatment, finally tertiary treatment such as adsorption, membrane filtration, membrane distillation, distillation, advanced oxidation processes, solvent extraction, and disinfection.
Anaerobic treatment of pharmaceutical wastewater
In most conventional wastewater treatment plants, the biological part plays a major role in the degradation of pharmaceutical compounds (Pugazhendi et al. 2022). Given the high organic content of these wastewaters, anaerobic methods have been proposed as sustainable, low-cost, low-nutrient, low-surface areas, and effective methods for drug degradation (Khadir et al. 2020). Anaerobic digesters (Rorke et al. 2022), membrane bioreactors (Chen et al. 2020), up-flow anaerobic sludge beds (Kong and Shi 2022), and anaerobic sequencing batch reactors are the main technologies for anaerobic treatment plants (Chaturvedi et al. 2022).
Huang et al. (2018) and Pugazhendi et al. (2022) mentioned that anaerobic treatment is an environmentally friendly treatment method that can generate renewable energy in methane. In contrast, some antibiotics can severely inhibit the stability of microorganisms and the performance of anaerobic processes (Aziz et al. 2022; Wang et al. 2022). In addition, few studies have investigated the anaerobic biodegradation properties of wastewaters containing complex organic compounds, including sulfamethoxazole pharmaceutical wastewaters, and little is known about the feasibility of using anaerobic digestion to treat these types of wastewaters (Chen et al. 2018; Zahedi et al. 2022).
Anaerobic digestion is becoming increasingly important because of its economical and efficient way of recovering carbon in renewable biogas (Xu et al. 2021; Samoraj et al. 2022). Harb et al. (2019) showed that anaerobic systems could promote the degradation of typical persistent compounds such as sulfamethoxazole, trimethoprim, clozapine, triclocarban, and amitriptyline, with a removal rate of greater than 80%. On the other hand, the low mineralization efficiency, low degradation efficiency, and poor stability of resistant organic wastes limit the application of anaerobic technology in antibiotics (Kong et al. 2019). Ailijiang et al. (2021) and Dai et al. (2022) reported that the application of electricity, stimulation of anaerobic systems, can improve the mineralization of recalcitrant nitrates and chlorine-substituted pollutants and can also improve the energy recovery. Guo et al. (2019) mentioned that the removal efficiency of antibiotics such as chloramphenicol increases from 53.3 to 89.7%, by increasing the voltage, while methane production more than tripled. Hu et al. (2020) and Jiang et al. (2021a, b) showed that electrical stimulation selects dominant functional bacteria and increases antibiotic resistance, improving antibiotic degradation and methane production by further affecting system performance.
Despite advanced scientific research, researchers have not been able to determine whether up-flow anaerobic sludge treatment systems for pharmaceutical wastewater are cost-effective in the long term (Chen et al. 2018; Collivignarelli et al. 2021). The Upflow Anaerobic Sludge Blanket (UASB) reactor has proven to be a competitive low-cost system for the direct treatment of municipal wastewater and some toxic compounds (Daud et al. 2018; Kong et Shi 2022). However, antibiotics such as carbamazepine CBZ have proven highly resistant to anaerobic treatment. In this sense, Moya-Llamas et al. (2021) reported its recalcitrant behavior by achieving low CBZ removal (< 15%) by anaerobic wastewater treatment. Also, other authors, such as Huang et al. (2018), found a COD removal of 45% under anaerobic conditions. Vassalle et al. (2020) found a lack of pollution elimination in the UASB reactor. However, some major problems such as long start-up periods, slow growth, anaerobic microorganism rates, and poor biomass retention limit the anaerobic process for pharmaceutical wastewater treatment (Huang et al. 2018).
To improve biological removal, Oliveira et al. (2020) and Sakurai et al. (2021) investigated the treatment (UASB) combined with constructed wetlands to treat discharged pharmaceutical wastewater. The system achieved an average of 95% pollutant removal, demonstrating the stability and potential of the UASB and the integration of constructed wetlands with pharmaceutical wastewater treatment (Vistanty and Crisnaningtyas 2021). In addition, dos Santos et al. (2021) and Sevda et al. (2020) developed a novel up-flow anaerobic sludge blanket with a bioelectrocatalysis system (UASB-BEC) to improve the treatment of wastewater containing acetopyrimidine. The results show that a higher applied current has a positive effect on acetopyrimidine (AP) degradation with high AP and total organic carbon (TOC) removal rates (96.3 ± 2.6% and 92.9 ± 3.2%), respectively (Wang et al. 2019). In parallel, Xu et al. (2021) and Sun et al. (2021) proposed the addition of zero-valent iron (ZVI) and granular activated carbon (GAC) to improve the anaerobic digestion of pharmaceutical wastewater. The results confirmed the synergistic effects of ZVI + GAC for COD removal (increased by 13.4%) and methane production (increased by 11.0%) (Dai et al. 2022). Moreover, microbial community analysis revealed that ZVI + GAC decrease species evenness and richness in bacteria and improve the removal of pharmaceutical intermediates (Wang et al. 2021a, b, c; Dai et al. 2022). Vassalle et al. (2020) proposed anaerobic wastewater pretreatment using microbial fuel cells (MFC) followed by aerobic treatment with microalgae. The combined process showed potential reductions in heavy metal concentrations and COD, TOC, nitrate, and phosphate observed in raw wastewater, 90.29, 97.05, 81.60, and 94.87%, respectively (Amit et al. 2020).
However, combined anaerobic wastewater treatment processes improve environmental sustainability and offer a more environmentally friendly biofuel production pathway (Choi et al. 2022; Song et al. 2022).
Pharmaceutical wastewater treatment by activated sludge
The activated sludge process is a traditional biological method commonly used to treat wastewater from the pharmaceutical industry (Quintelas et al. 2020; Nguyen et al. 2021). The pollutants are converted to gases and digested sludge, which can be safely released into the environment (Mareai et al. 2020; Hu et al. 2020). It has a lower capital cost and limited operating requirements than more advanced processing methods. In contrast, operational problems such as high energy consumption, production of large amounts of sludge and color, foaming, and swelling of the secondary clarifier are associated with activated sludge plants (Pilli et al. 2020; Barati et al. 2022).
Factors that affect the efficiency of a pharmaceutical activated sludge treatment plant include hydraulic retention time (Katam et al. 2021), temperature (Ogwueleka and Samson 2020), pH, dissolved oxygen, organic load, microbial communities, presence of toxic or recalcitrant substances (Yang et al. 2020; Hajji et al. 2021). These variables must be modified to account for wastewater treatment in the pharmaceutical industry (Mareai et al. 2020). For example, Sun et al. (2020a, b) mentioned that inoculum plays an important role in establishing bacterial communities in bioprocess reactors. And in addition, Jaén-Gil et al. 2021 have shown that diet composition affects the microbial composition and activity of activated sludge, thus its ability to biotransform drugs.
Zhao et al. (2020) discussed the difficulty of completely removing antibiotics by conventional biological methods and the spread during such treatment. Cheng et al. (2020) and Fan et al. (2022) mentioned that biodegradable feeds facilitate the simultaneous removal of antibiotics and ARMs in activated sludge processes. Zhang et al. (2020a, b) and Sun et al. (2020a, b) studied the degradation of amoxicillin in a sequencing bioreactor using sodium acetate as a cosubstrate. According to Zhang et al. (2021), this process removed nearly 100% of the amoxicillin and stabilized the chemical oxygen demand in the effluent. In addition, the total abundance of ARGs decreased by about 30%, and the proportion of bacteria resistant to major antibiotics decreased by about 9%. The overall abundance of ARG-encoding plasmids was reduced by about 30%, implying that the risk of ARG transmission was reduced again (Zhang et al. 2021). Kanafin et al. (2021a, b, c) and Rios-Miguel et al. (2021) mentioned that the sequential feed-activated sludge process could not effectively remove the target drugs. Based on using a sequential batch reactor in an aeration chamber in Swarzewo, Kołecka et al. (2020) conducted a pharmaceutical wastewater treatment study with a calculated removal rate for conventional pollutants of 94.4–99.5%. The risk quotients (RQs) calculated for the drugs analyzed indicated a low environmental risk for the selected species. On the other hand, a negative effect on biota due to the prolonged presence of diclofenac cannot be excluded still, according to (Kołecka et al. 2020).
Hui et al. (2021) and Stévenne et al. (2021) considered different strategies for the biological treatment of the antibiotic metronidazole: bioaugmentation, bioacclimation, and biostimulation. Aboudalle et al. (2021) mentioned that conventional biological treatment with activated sludge resulted in 58.1% mineralization, while metronidazole by-product mineralization was higher than in the combination of biomagnification and biostimulation. Thus, the mineralization rate was 96.1%, again, according to (Aboudalle et al. 2021).
Paśmionka et al. (2021) and Wang et al. (2021a, b, c) set on the power of the activated sludge process for the removal of fecal coliform bacteria and Escherichia coli resistance to antibiotics in treated wastewater. Notwithstanding a 99% reduction of the pollution in the biologically treated wastewater, 89% of the E. coli in the isolates were resistant to the antibiotics tested. In comparison, 100% of the isolates were susceptible to metronidazole (Hawrylik and Butarewicz 2021).
Complete degradation of caffeine and ibuprofen and partial degradation of metronidazole between 12 and 27% were found by Kanafin et al. (2021a, b, c) after adopting the activated sludge process.
The removal of acetaminophen (ACT), one of the most widely used pharmaceutical compounds, and chemical oxygen demand (COD) was studied by Park and Oh (2020) and Rios-Miguel et al. (2021) using a fully environmentally friendly biological method, the bioreactor cycle (BRC). The removal efficiencies of ACT and COD are 98% and 95%, respectively, under the 18-h cycle and concentrations of 500 mg/L ACT and 7600 mg/L COD (Khoshvaght et al. 2021).
Kanafin et al. (2021a, b, c) mentioned that most antibiotics, such as metronidazole, affected nitrification’s kinetics and metabolic behavior and activated sludge’s heterotrophic activities in batch culture. According to Velasco-Garduño et al. (2021), increasing the initial concentration of metronidazole decreases COD and ammonium removal efficiencies, nitrate production efficiencies, and specific substrate consumption rates. Metronidazole has a greater effect on heterotrophic activity than on nitrification activity. In addition, its inhibitory effect on nitrite oxidation is greater than that of ammonium oxidation (Kanafin et al. 2021a, b, c).
To increase the removal of pharmaceuticals, Huidobro-López et al. (2022) conducted a comparison study between the use of a screw filter (VF) pilot and the actual removal rate obtained by the activated sludge (AS) treatment system for antibiotic treatment. The results suggest that the auger filter can be considered a promising alternative to traditional processes (Aemig et al. 2020). In addition, based on the calculated RQ, the AS system indicated that the wastewater had a high risk of algae. In general, the VF system reduced the ecotoxicity of antibiotics (Shokoohi et al. 2020). On the other hand, Alfonso-Muniozguren et al. (2021) and Joannis-Cassan et al. (2021) proposed a benchtop reactor that was inoculated with activated sludge and fed with a synthetic medium for the treatment of pharmaceuticals such as ibuprofen (IBU) and paracetamol (PARA). According to Alfonso-Muniozguren et al. (2021), removal efficiency reached 99.1 and 99.5% values independent of the initial IBU concentration. For PARA, the removal percentage ranged from 93.3 to 98.8, decreasing with increasing initial concentration again (Quintelas et al. 2020).
Pharmaceutical wastewater treatment by membrane bioreactor
The MBR membrane bioreactor combines a membrane module and a bioreactor, which has been widely used as an advanced method for treating pharmaceutical wastewater (Hosseinpour et al. 2021; Liu et al. 2022). This type of bioreactor has several operational advantages: low sludge production, good effluent quality, better organic matter removal, longer sludge residence time maintenance, and better resistance to toxic substances (Guo et al. 2020a, b; Al-Asheh et al. 2021).
Despite the significant advantages of MBR, Campo et al. (2021) and Sengar and Vijayanandan (2022) mentioned that membrane fouling remains a major problem in reducing membrane permeability. This significantly affects the performance and longevity of the membrane and increases the operating cost of the MBR (Cheng et al. 2021). However, Al-Asheh et al. (2021) and Fakhri et al. (2021a, b) proposed an aerobic hollow fiber membrane bioreactor to treat pharmaceutical wastewater containing antibiotics. The endophyte Penicillium has been used as a natural fire extinguisher to control biofouling problems and improve antibiotic removal efficiency. According to Fakhri et al. (2021a, b), the bioincrease in Penicillium endophyte resulted in changes in antibiotic removal efficiency and significantly reduced transmembrane pressure, thereby reducing membrane fouling. In addition, Fakhri et al. (2021a, b) used the saprophytic fungus Trichocladium canadense as a bioaugmenter in an anaerobic membrane bioreactor (AnMBR) for the removal of antibiotics such as erythromycin (ERY), sulfamethoxazole (SMX) and tetracycline (TET) from wastewater. The results indicated that the biological fouling of the membrane was slowed by 25%, with the removal of chemical oxygen demand increased by 16% and more efficient removal of ERY and SMX. In parallel, proposed a cocktail of bacteriophages (Pyophage) in an anaerobic membrane bioreactor for wastewater treatment containing a high concentration of erythromycin, tetracycline, and sulfamethoxazole. According to Aydin and Can (2020), the results indicate that the Pyophage cocktail significantly contributes to the decrease (45%) in transmembrane pressure while also suppressing biofilm-producing bacteria.
In the same context, Hosseinpour et al. (2021) prepared a polypropylene (PP) membrane by incorporating carboxylated functionalized nanodiamonds (-COOH) and also polyethylene glycol (-PEG) to reduce membrane fouling in pharmaceutical wastewater treatment. The results indicated that the COD removal was more than 91%, and incorporating nanodiamond in PP membrane can reduce membrane fouling in MBR again, according to Hosseinpour et al. (2021). In addition, Aydin et al. (2022) proposed a bioaugmenter MBR with Haematococcus microalgae for the treatment of antibiotics such as sulfamethoxazole (SMX), tetracycline (TET), and erythromycin (ERY). In the biological reactor, the membrane fouling was decreased by 33%, and chemical oxygen demand removal grew by 6% (Aydin et al. 2022). Also, Zhang et al. (2020a, b) conducted a comparative study of three anoxic/aerobic membrane bioreactors (AO-MBRs), including MBR moving bed biofilm (MBRa), MBR fixed biofilm (MBRb), and AO-MBR (MBRc) for the treatment of wastewater containing antibiotics such as tetracycline (TC) and norfloxacin (NOR). The results showed that MBRb impacted antibiotic removal and membrane fouling mitigation compared to two bioreactors. The removal rate of TC in MBRb reached 65% and 46% for NOR (Zhang et al. 2020a, b).
Anaerobic membrane bioreactors (AnMBRs) can treat complex waste streams, recover energy, and produce nutrient-rich wastewater for irrigation (Lou et al. 2020). Based on (Guo et al. 2020a, b) analyses, the results showed that the removal efficiency of antibiotics and ARMs in the AnMBR system ranged from 34.6 to 100%. According to Wang et al. (2020a, b), the results showed that approximately 61.8% to 77.5% of the antibiotics were degraded, and the MBR sludge adsorbed an average of 22.5% to 38.2% of the antibiotics. Zarei-Baygi et al. (2020) proposed AnMBR to treat domestic wastewater containing antibiotics (sulfamethoxazole, ampicillin, and erythromycin). Overall, these results provide useful information on the association of ARMs with microbial community dynamics in AnMBR, which is necessary to develop operational and design strategies to reduce the spread of antibiotic resistance in the environment. On the other hand, Xu et al. (2019a, b) investigated antibiotic removal by a sequencing membrane bioreactor (SMBR) for commonly used veterinary antibiotics, namely sulfonamides, tetracyclines, and fluoroquinolones. The results show that SMBR can effectively remove sulfonamides and tetracyclines (> 90%), while the removal rate of fluoroquinolones is lower (< 70%). In addition, Arcanjo et al. (2021) evaluated the performance of a hybrid anaerobic permeation membrane bioreactor coupled with a membrane distillation system (AnOMBR-MD) to remove PhAC from wastewater. Dissolved organic carbon and P-PO 4 3-removal rates reached 97.2% and 98.0%, respectively. N-NH4 + accumulates in the bioreactor because it cannot be removed by anaerobic treatment. However, the overall removal rate of PhACs by the AnOMBR-MD system was greater than 96.4%.
Notably, antibiotics inhibit the sludge growth of the biological process (Wang et al. 2020a, b). To this end, Xu et al. (2019a, b) investigated the removal pathways of sulfadiazine (SDZ) and tetracycline (TC) and their roles in microbial community formation. The results showed that the MBR system removed more than 90% of the TC in the diet, while the removal rate of SDZ decreased from 100 to 40% with increasing SDZ concentration.
Hybrid treatment of pharmaceutical wastewater
Various other methods of treating pharmaceutical wastewater, including chemical, physical, and biological procedures, have been developed by researchers such as Angeles et al. (2020) and Taoufik et al. (2021). Indeed biological wastewater treatment is an environmentally friendly method that forms less sludge and is relatively inexpensive (Changotra et al. 2019; Khan et al. 2021a, b, c). But the process is less effective in removing drug residues and requires a lot of maintenance (Nagda et al. 2021). In contrast, physicochemical methods represent promising treatment methods for pharmaceutical wastewater (Zamri et al. 2021; Nidheesh et al. 2021). But they suffer from significant drawbacks such as economic inefficiency production of toxic by-products, higher investment, membrane fouling accumulation in the filtration, high energy demand, and decreased sludge absorption capacity (Khan et al. 2021a, b, c; Nagda et al. 2021; Zamri et al. 2021). To overcome the limitations of individual methods, researchers have turned to hybrid processes (Saidulu et al. 2021; Mojiri et al. 2020), in which all physical, chemical, and biological treatment methods are integrated to facilitate the effective removal of various emerging contaminants (Gonzalez-Tineo et al. 2020; Top et al. 2020). Hybrid systems can generate bioenergy, which helps reduce the system’s operating costs (Forruque et al. 2021; Jaén-Gil et al. 2021).
Different treatment methods can be used to remove emerging pollutants quickly and eco-efficiently (Almaguer et al. 2021; García et al. 2021). Pirsaheb et al. (2020) explored tests of several hybrid systems by first applying a biological treatment, followed by physical or chemical treatment. Among these tests, Dhangar and Kumar 2020 mentioned that membrane bioreactor technology followed by membrane filtration is one of the most effective treatments for removing emerging pharmaceutical contaminants. Similarly, hybrid systems using biosorption and biological treatment have shown promising potential for drug disposal (Mojiri et al. 2020; Rathi and Kumar 2021). In particular, Hu et al. (2021a, b) and Qiu et al. (2021) mentioned that hybrid systems combine activated sludge processes with physical processes such as ultrafiltration, reverse osmosis, and gamma radiation, the most cost-effective technology, and provide better removal of trace organic pollutants. In parallel, hybrid systems membrane bioreactors combined with UV oxidation activated carbon and ultrasound after ozonation have completely degraded many drugs (Monteoliva-García et al. 2020; Rostam and Taghizadeh 2020).
Recently, the POA advanced oxidation process has received attention as an effective method for the complete mineralization of pharmaceuticals (Guo et al. 2020a, b; Giannakis et al. 2021). The acute operating costs of the mismanagement of energy and chemicals are the main disadvantage of these processes compared to the high energy and chemical consumption (Forruque et al. 2021; Nidheesh et al. 2021). Therefore, POA is often used with other treatments (Saidulu et al. 2021). Chemical, biological hybrid treatment can effectively treat pharmaceutical wastewater degradation (Changotra et al. 2019; Angeles et al. 2020). The combination of PDOs and biological procedures within this framework can help reduce contaminant concentrations to desired levels, thereby ensuring better water quality (Mukimin et al. 2020; Olvera-Vargas et al. 2021). Arellano et al. (2020) and Khan et al. (2021a, b, c) recommended the Fenton process as an appropriate choice for pretreatment technology before biological treatment. Taoufik et al. (2021) also stated that the advantages of this hybrid technology are low energy costs, efficient degradation process, and production of non-toxic by-products. On the other hand, Almaguer et al. (2021) and Li et al. (2022) mentioned that the combined treatment of AOP and microalgae is a very environmentally friendly technology, as it can provide microalgae biomass as feedstock for biofuel production in addition to wastewater treatment (Samal et al. 2022).
Conventional activated sludge treatments do not always provide satisfactory results for the removal of pharmaceuticals, but they remain the most commonly used methods globally (Kamali et al. 2022; Elshikh et al. 2022). However, the incomplete removal of biodegradable pollutants and biorecycling intermediates produced in wastewater treatment plants is a major problem (Leiviskä and Risteelä 2022). To remediation poorly biodegradable effluents, Ortiz-Marin et al. (2020) and Pandis et al. (2022) proposed UV/H2O2 PDO as a pretreatment step for biological treatment. In particular, according to Jaén-Gil et al. (2021), the removal of metoprolol and metoprolol acid from hospital wastewater using UV/H2O2 before and after conventional activated sludge was ranked as the most efficient combination with the highest removal (86% and 100%). On the other hand, a hybrid system of biological treatment by activated sludge and adsorption on activated carbon has been suggested by Viegas et al. (2020) and García et al. (2021) to remove three drugs such as acetaminophen, caffeine, and ibuprofen. According to Ferrer-Polonio et al. (2020), results show that the effluent produced by this system is of better quality than that obtained from conventional individual treatment in terms of COD concentration, turbidity, and soluble microbial products. In the same context, Çifçi and Meriç (2022) and Cadamuro et al. (2022) studied a combined treatment system using activated sludge and biofilter with slag as filtering materials for the removal of ceftriaxone (CEF) and amoxicillin (AMX). The results showed that the hybrid system was able to effectively remove about 87.53% (for AMX) and 93.17% (for CEF), according to Pirsaheb et al. (2020)
The hybrid membrane process is a powerful solution for removing emerging contaminants from wastewater (Khan and Boddu 2021; Qiu et al. 2021). Using these processes, water quality can be achieved for sustainable reuse in the hydrological cycle while minimizing environmental and economic impacts (Molinari et al. 2020; Schwaller et al. 2021). In particular, biological treatment by an ultrafiltration membrane bioreactor (UF-MBR) after adsorption on granular activated carbon, ozonation, and UV/H2O2 has been tested by Mousel et al. (2021). The results are generally interested in combining UF-MBR biological treatment with GAC adsorption, ozonation, or AOP to remove drug residues (Töre et al. 2021). Each combination of UF-MBR with one of the three additional treatments achieved removal efficiencies greater than 80% for most species studied again, according to Mousel et al. (2021).
Researchers have developed other hybrid treatment systems to study the impact of combined treatment on wastewater detoxification, including coagulation, biological treatment, and beta process (Ahmad Sadaf et al. 2022; Kim et al. 2022). According to Changotra et al. (2020), this process resulted in efficient degradation and detoxification with 94% and 89%, respectively, high drug removal rates. In addition, ozone (O3), activated carbon (AC), and biological treatment have been studied by Jhunjhunwala et al. (2021) and Choi et al. (2022) for the degradation of levosulpiride. Using the minimum dose of activated carbon, ozone, and run time, the percentage removal of levosulpiride obtained was about 76% and 61% for degradation and detoxification, respectively, again according to (Jhunjhunwala et al. 2021).
Wastewater treatment options
Industrialization plays an important role in economic growth and development (Ali et al. 2020; Usman and Balsalobre-Lorente 2022). However, the number of industries has also led to a rapid increase in pollution due to poor industrial wastewater management (Yenkie 2019; Ali et al. 2020). Technological solutions for wastewater treatment range from traditional methods to advanced technologies (Saghafi et al. 2019; Salamirad et al. 2021). However, choosing the best wastewater treatment technology can be a complex task. Several alternatives are available, and multiple technical, economic, social, regulatory, governmental, and environmental criteria are involved in the selection process (Kamali et al. 2019a, b; Boer et al. 2022).
To address this problem, various multi-criteria decision support methods have been used to integrate multiple environmental application criteria (Delanka-Pedige et al. 2022). Ullah et al. (2020) developed a comprehensive review of the latest technologies in wastewater treatment implementer dusting Microsoft Visual Studio 2010. This system is divided into four levels of treatment depending on the complexity of the wastewater and the level of treatment required to have the primary, secondary, tertiary, and hybrid treatments. In addition, Mannina et al. (2019) and Hammond et al. (2021) mentioned that the decision support system enables customization of treatment groups at the planning stage at minimal cost, eliminates errors in the planning and design stages, facilitates decision-making by refining alternative solutions based on user needs and current conditions, incorporates customer needs, and promotes developmental sustainability.
Meanwhile, Mahajan et al. (2022) and Gupta and Kumar (2022) evaluated five wastewater treatment technologies used in Pakistan against ten criteria using the fuzzy multi-criteria decision-making method VIKOR. Among the selected criteria, land requirements, energy consumption, and excessive sludge production had the most pronounced effect on decision-making (Saghafi et al. 2019). The study results showed activated sludge was the most suitable technology for industrial wastewater treatment in Pakistan (Ali et al. 2020).
The treatment method’s efficiency and sustainability are the most important criteria for selecting sustainable wastewater treatment methods (Koohathongsumrit and Meethom 2022). Kamali et al. (2019a, b) investigated a Fuzzy-Delphi approach to evaluate 17 parameters incorporating technical, economic, environmental, and social criteria to classify nine treatment technologies into two categories (physical–chemical and biological processes. The results show that membrane technology and sludge blanket technology are the most promising methods to treat highly polluting emerging industrial pollutants still, according to Kamali et al. (2019a, b).
And in addition, Kamali et al. (2019a, b) and Parhizgarsharif et al. (2019) proposed a new hybrid methodology based on the best–worst method (BWM) and the behavioral technique of preference ordering by similarity to the ideal solution (BTOPSIS). BWM incorporates consistency checks, while BTOPSIS can model the decision-makers risk-taking behavior (Liu et al. 2019). Based on different levels of decision-makers loss-aversion, results indicate that energy consumption and a fixed-film integrated activated-sludge reactor are the most efficient criterion and the most effective technology (Salamirad et al. 2021).
For example, Cunha et al. (2021) have carried out tests based on a multi-criteria decision-making method (MCDM) to evaluate the cheapest UVC/H2O2 process with the lowest associated environmental impacts coupled with the highest degradation rate. The results showed that E7 experiment ([H2O2] 0 = 43.5 mg L−1; E UVC = 15.0 W m−2; k IMD = 0.236 s−1) was considered to fulfill the three criteria in a balanced way again according to (Cunha et al. 2021).
According to several authors, the advantages and limitations of wastewater treatment processes have been summarized in Table 2
Table 2 represents a comparison of the different liquid waste treatment techniques produced by the pharmaceutical industry in terms of advantages and disadvantages in terms of degradation efficiency, investment and operating cost and performance.
Conclusion
It can be concluded that industrial discharges of pharmaceutical products considerably impact the environment, the ecosystem, and health. The pollution generated by these discharges is becoming more and more worrying. It also causes severe damage to the proper functioning of wastewater treatment plants because antibiotics have a considerable impact on these plants. These discharges must be treated to eliminate the contaminants. Therefore, the treatment of pollutants is necessary to represent a gain for a better quality of life for citizens, an improvement of the health system, and positive socioeconomic benefits. In addition, there are many techniques of biological treatment, among others.
This study, via a review of the literature on treating liquid waste from the pharmaceutical industry, aims to highlight the negative impacts of these discharges on the environment, human health, and treatment plants. In addition, the study helped illustrate the possible techniques to eliminate pollution from pharmaceutical discharges to minimize the impacts effectively.
This literature review does not provide a single viable treatment technique in terms of efficiency, cost, and performance. Therefore, we propose a combination of treatments toward an optimal technique called hybrid. It should be noted that the advantages of this technique involve low energy cost, efficient degradation process, and generation of non-toxic by-products.
Water in the pharmaceutical industry must be controlled both upstream and downstream of the plant:
-
Upstream, water must be saved by rationalizing and recycling treated water.
-
Downstream, all types of pollution must be treated before discharge into the environment, with recycling of treated water.
For downstream actions, among the biological treatments recommended for pharmaceutical waters, we can mention.
-
Membrane processes
-
Biological treatment by activated sludge
-
Techniques using rotating disks as biomass support
-
Membrane bioreactors with high antibiotic reduction efficiency
-
Anaerobic treatment techniques alone or combined with aerobic treatment
It is understood that the appropriate treatment choice must be entrusted to the technique that effectively meets the requirements of the regulatory standards.
Data availability
Not applicable.
References
Abdouni A, El S, Bouhout I, Merimi BH, Haboubi K (2021) Physicochemical characterization of wastewater from the Al-Hoceima slaughterhouse in Morocco. Caspian J Environ Sci 19(3):423–429
Aboudalle A, Djelal H, Domergue L, Fourcade F, Amrane A (2021) A novel system coupling an electro-fenton process and an advanced biological process to remove a pharmaceutical compound, metronidazole. J Hazard Mater 415:125705
Abou-tammame D, Zouhri A, Boutarfa A, Fathi J, Aboutayeb R (2022) The effect of purified wastewater on the physicochemical properties of agricultural soils in Chaouia in Morocco. J Ecol Eng 23(1):34–42
Abuhasel K, Kchaou M, Alquraish M, Munusamy Y, Jeng YT (2021) Oily wastewater treatment: overview of conventional and modern methods, challenges, and future opportunities. Water 13(7):980
Aemig Q, Steyer D, Hélias A (2020) Life cycle assessment at the scale of france on human health and aquatic environment of micropollutants released by wastewater treatment plants. Environ Contam 2:26
Agrawal K, Bhatt A, Bhardwaj N, Kumar B, Verma P (2020) Integrated approach for the treatment of industrial effluent by physico-chemical and microbiological process for sustainable environment. In: Maulin P, Banerjee SA (eds) Combined application of physico-chemical and microbiological processes for industrial effluent treatment. Springer, Singapore, pp 119–143
Ahmad S, Abbasi BBK, Nazir MS, Abdullah MA (2022) Metal organic frameworks (MOFs) as formidable candidate for pharmaceutical wastewater treatment. In: Eric L, Muthu SS, Khadir A (eds) Inorganic–organic composites for water and wastewater treatment: empreintes environnementales et éco-conception des produits et procédés, vol 2. Springer, Singapore, pp 37–63
Ailijiang N, Chang J, Liang P, Zhang X, Huang X (2021) Electrical stimulation on biodegradation of phenolics in a novel anaerobic–aerobic-coupled upflow bioelectrochemical reactor. Chem Eng J 421:127840
Ait-Mouheb N, Mayaux PL, Mateo-Sagasta J, Hartani T, Molle B (2020) Chapter 5—Water reuse: a resource for mediterranean agriculture. In: Mehrez Z, Brocca L, Tramblay Y, Molle F (eds) Water resources in the mediterranean region. Elsevier, pp 107–136
Al-Asheh S, Bagheri M, Aidan A (2021) Membrane bioreactor for wastewater treatment: a review. Case Stud Chem Environ Eng 4:100109
Alfonso-Muniozguren P, Serna-Galvis EA, Bussemaker M, Torres-Palma RA, Lee J (2021) A review on pharmaceuticals removal from waters by single and combined biological, membrane filtration and ultrasound systems. Ultrason Sonochem 76:105656
Ali Y, Pervez H, Khan J (2020) Selection of the most feasible wastewater treatment technology in pakistan using multi-criteria decision-making (MCDM). Water Conserv Sci Eng 5(3):199–213
Almaguer MA, Cruz YR, da Fonseca FV (2021) Combination of advanced oxidation processes and microalgae aiming at recalcitrant wastewater treatment and algal biomass production: a review. Environ Process 8:483–509
Amit JKN, Ghosh UK (2020) Microalgal remediation of anaerobic pretreated pharmaceutical wastewater for sustainable biodiesel production and electricity generation. J Water Process Eng 35:101192
Angeles F, Luisa RA, Mullen IJ, Huang CW, Khunjar W, Sirotkin HI, McElroy AE, Aga DS (2020) Assessing pharmaceutical removal and reduction in toxicity provided by advanced wastewater treatment systems. Environ Sci Water Res Technol 6(1):62–77
Anjum F, Khan IM, Kim J, Aslam M, Blandin G, Heran M, Lesage G (2021) Trends and progress in ANMBR for domestic wastewater treatment and their impacts on process efficiency and membrane fouling. Environ Technol Innov 21:101204
Arcanjo GS, Ricci BC, dos Santos CR, Costa FCR, Silva UCM, Mounteer AH, Koch K, da Silva PR, Santos VL, Amaral MCS (2021) Effective removal of pharmaceutical compounds and estrogenic activity by a hybrid anaerobic osmotic membrane bioreactor—membrane distillation system treating municipal sewage. Chem Eng J 416:129151
Archer E, Volschenk M, Brocker L, Wolfaardt GM (2021) A two-year study of emerging micro-pollutants and drugs of abuse in two western cape wastewater treatment works (South Africa). Chemosphere 285:131460
Arellano M, Oturan N, Pazos M, Sanromán MÁ, Oturan MA (2020) Coupling electro-fenton process to a biological treatment, a new methodology for the removal of ionic liquids? Sep Purif Technol 233:115990
Ayankojo AG, Reut J, Ciocan V, Öpik A, Syritski V (2020) Molecularly imprinted polymer-based sensor for electrochemical detection of erythromycin. Talanta 209:120502
Aydin S, Can K (2020) Pyophage cocktail for the biocontrol of membrane fouling and its effect in aerobic microbial biofilm community during the treatment of antibiotics. Biores Technol 318:123965
Aydin S, Ünlü İD, Arabacı DN, Duru ÖA (2022) Evaluating the effect of microalga haematococcus pluvialis bioaugmentation on aerobic membrane bioreactor in terms of performance, membrane fouling and microbial community structure. Sci Total Environ 807:149908
Aziz A, Sengar A, Basheer F, Farooqi IH, Isa MH (2022) Anaerobic digestion in the elimination of antibiotics and antibiotic-resistant genes from the environment—a comprehensive review. J Environ Chem Eng 10(1):106423
Azizan NA, Zahida AY, Abdullah N (2021) Pharmaceutical compounds in anaerobic digestion: a review on the removals and effect to the process performance. J Environ Chem Eng 9(5):105926
Barakat A, Hilali A, El Baghdadi M, Touhami F (2020) Assessment of shallow groundwater quality and its suitability for drinking purpose near the Béni-Mellal wastewater treatment lagoon (Morocco). Hum Ecol Risk Assess Int J 26(6):1476–1495
Barati B, Zafar FF, Wang S (2022) Different waste management methods, applications, and limitations. In: Abd El-Fatah A, Wang Q, Huang J (eds) Waste-to-energy: recent developments and future perspectives towards circular economy. Springer, Cham, pp 21–58
Beiras R (2021) Chapter 6—Environmental risk assessment of pharmaceutical and personal care products in estuarine and coastal waters. In: Juan C, Álvarez D, Jiménez-Cisneros B (eds) Pharmaceuticals in marine and coastal environments. Estuarine and coastal sciences series, vol 1. Elsevier, pp 195–252
Belazreg NE, Houda MH, Şen Z, Ferhati A (2021) Peak flow assessment of El-Ham Wadi in Hodna basin case study. Arab J Geosci 15(1):22
Bilal M, Mehmood S, Rasheed T, Iqbal HMN (2020) Antibiotics traces in the aquatic environment: persistence and adverse environmental impact. Curr Opin Environ Sci Health Environ Monit Assess Water Energy Food Nexus 13:68–74
Bio S, Nunes B (2020) Acute effects of diclofenac on Zebrafish: indications of oxidative effects and damages at environmentally realistic levels of exposure. Environ Toxicol Pharmacol 78:103394
Bu Q, Cao Y, Gang Yu, He X, Zhang H, Sun J, Yun M, Cao Z (2020) Identifying targets of potential concern by a screening level ecological risk assessment of human use pharmaceuticals in China. Chemosphere 246:125818
Button M, Cosway K, Sui J, Weber K (2019) Impacts and fate of triclosan and sulfamethoxazole in intensified re-circulating vertical flow constructed wetlands. Sci Total Environ 649:1017–1028
Cadamuro RD, Rogovski P, Prá ID, Guterres IZ, Carmargo AF, Bonatto C, Scapini T et al (2022) Chapter 14—Trends in biofiltration applied to remove pharmaceuticals and personal care products from wastewater. In: Maulin S, Rodriguez-Couto S, Biswas J (eds) An innovative role of biofiltration in wastewater treatment plants (WWTPs). Elsevier, pp 267–284
Campo R, Lubello C, Lotti T, Di Bella G (2021) Aerobic granular sludge-membrane bioreactor (AGS–MBR) as a novel configuration for wastewater treatment and fouling mitigation: a mini-review. Membranes 11(4):261
Chami K, Feltin N, Gaffet E, Lacour S, Lassus M, Le Bihan O, Niaudet A, Ricaud M, Nesslany F (2021) Les nanomatériaux manufacturés dans l’environnement professionnel : un aperçu de l’état de l’art. Arch Des Maladies Professionnelles Et De L’environnement 82(1):51–68
Changotra R, Rajput H, Dhir A (2019) Treatment of real pharmaceutical wastewater using combined approach of fenton applications and aerobic biological treatment. J Photochem Photobiol A 376:175–184
Changotra R, Rajput H, Guin JP, Khader SA, Dhir A (2020) Techno-economical evaluation of coupling ionizing radiation and biological treatment process for the remediation of real pharmaceutical wastewater. J Clean Prod 242:118544
Chaturvedi P, Shukla P, Giri BS, Chowdhary P, Chandra R, Gupta P, Pandey A (2021) Prevalence and hazardous impact of pharmaceutical and personal care products and antibiotics in environment: a review on emerging contaminants. Environ Res 194:110664
Chaturvedi A, Singh RS, Jaiswal RP (2022) Chapter 27—Hybrid bioreactor in combination with ozone-based technologies for industrial wastewater treatment. In: Maulin S, Rodriguez-Couto S, Biswas J (eds) Development in wastewater treatment research and processes. Elsevier, pp 629–650
Chaubey AK, Patel M, Mohan D (2021) Synthesis of engineered biochar for aqueous pharmaceutical removal. Avril EGU21-9358
Chen Yi, He S, Zhou M, Pan T, Yujia Xu, Gao Y, Wang H (2018) Feasibility assessment of up-flow anaerobic sludge blanket treatment of sulfamethoxazole pharmaceutical wastewater. Front Environ Sci Eng 12(5):13
Chen L, Peijin Cheng Lu, Ye HC, Xiangyang Xu, Zhu L (2020) Biological performance and fouling mitigation in the biochar-amended anaerobic membrane bioreactor (AnMBR) treating pharmaceutical wastewater. Biores Technol 302:122805
Chen G, Bai R, Zhang Y, Zhao B, Xiao Y (2022) Application of metagenomics to biological wastewater treatment. Sci Total Environ 807:150737
Cheng D, Ngo HH, Guo W, Chang SW, Nguyen DD, Liu Y, Wei Q, Wei D (2020) A critical review on antibiotics and hormones in swine wastewater: water pollution problems and control approaches. J Hazard Mater 387:121682
Cheng D, Ngo HH, Guo W, Chang SW, Nguyen DD, Nguyen QA, Zhang J, Liang S (2021) Improving sulfonamide antibiotics removal from swine wastewater by supplying a new pomelo peel derived biochar in an anaerobic membrane bioreactor. Biores Technol 319:124160
Choi S, Yoom H, Son H, Seo C, Kim K, Lee Y, Kim YM (2022) Removal efficiency of organic micropollutants in successive wastewater treatment steps in a full-scale wastewater treatment plant: bench-scale application of tertiary treatment processes to improve removal of organic micropollutants persisting after secondary treatment. Chemosphere 288:132629
Çifçi Dİ, Meriç S (2022) Chapter 19—A critical review on biofiltration for wastewater treatment: focus on organic micropollutants. In: Maulin S, Rodriguez-Couto S, Biswas J (eds) An innovative role of biofiltration in wastewater treatment plants (WWTPs). Elsevier, pp 369–388
Collivignarelli MC, Abbà A, Caccamo FM, Calatroni S, Torretta V, Katsoyiannis IA, Miino MC, Rada EC (2021) Applications of Up-flow anaerobic sludge blanket (UASB) and characteristics of its microbial community: a review of bibliometric trend and recent findings. Int J Environ Res Public Health 18(19):10326
Cunha IL, Climaco JG, Vieira V, Kulay L (2021) A multi-criteria decision-making approach to evaluate different UVC/H2O2 systems in wastewater treatment. Processes 9(12):2252
Dahchour A, El Hajjaji S, Dhiba D, Ghosh SK (2021) Circular economy in Morocco: status and perspectives. In: Sadhan KG, Ghosh SK (eds) Circular economy: recent trends in global perspective. Springer, Singapore, pp 29–67
Dai C, Yang L, Wang J, Li D, Zhang Y, Zhou X (2022) Enhancing anaerobic digestion of pharmaceutical industries wastewater with the composite addition of zero valent iron (ZVI) and granular activated carbon (GAC). Biores Technol 346:126566
Daud MK, Rizvi H, Akram MF, Ali S, Rizwan M, Nafees M, Jin ZS (2018) Review of upflow anaerobic sludge blanket reactor technology: effect of different parameters and developments for domestic wastewater treatment. J Chem 2018:e1596319
de Boer S, González-Rodríguez J, Conde JJ, Moreira MT (2022) Benchmarking tertiary water treatments for the removal of micropollutants and pathogens based on operational and sustainability criteria. J Water Process Eng 46:102587
de Oliveira M, Frihling BEF, Velasques J, Filho FJCM, Cavalheri PS, Migliolo L (2020) Pharmaceuticals residues and xenobiotics contaminants: occurrence, analytical techniques and sustainable alternatives for wastewater treatment. Sci Total Environ 705:135568
Dehkordi SK, Paknejad H, Blaha L, Svecova H, Grabic R, Simek Z, Otoupalikova A, Bittner M (2021) Instrumental and Bioanalytical assessment of pharmaceuticals and hormone-like compounds in a major drinking water source—wastewater receiving Zayandeh Rood River, Iran. In: Environmental science and pollution research
Delanka-Pedige HMK, Zhang Y, Nirmalakhandan N (2022) Algal wastewater treatment integrated with carbon adsorption and ozonation for water reclamation: multi-criteria comparison with conventional pathways. Algal Res 61:102581
Deng F, Zhang D, Yang L, Lijuan Li YuLu, Wang J, Fan Y, Zhu Y, Li X, Zhang Y (2022) Effects of antibiotics and heavy metals on denitrification in shallow Eutrophic lakes. Chemosphere 291:132948
Devault DA, Amalric L, Bristeau S, Cruz J, Tapie N, Karolak S, Budzinski H, Lévi Y (2021) Removal efficiency of emerging micropollutants in biofilter wastewater treatment plants in tropical areas. Environ Sci Pollut Res 28(9):10940–10966
Dey S, Bano F, Malik A (2019) 1—Pharmaceuticals and personal care product (PPCP) contamination—a global discharge inventory. In: Majeti NVP, Vithanage M, Kapley A (eds) Pharmaceuticals and personal care products: waste management and treatment technology. Butterworth-Heinemann, pp 1–26
Dhangar K, Kumar M (2020) Tricks and tracks in removal of emerging contaminants from the wastewater through hybrid treatment systems: a review. Sci Total Environ 738:140320
dos Santos AM, dos Santos AM, da Silva PA, Zepka LQ, Jacob-Lopes E (2021) Biological swine wastewater treatment. In: Applied water science, vol 1. Wiley, pp 227–253
Dutta S, Bhattacharjee J (2022) Chapter 1—A comparative study between physicochemical and biological methods for effective removal of textile dye from wastewater. In: Shah MP, Rodriguez-Couto S, Kapoor RP (eds) Development in wastewater treatment research and processes. Elsevier, pp 1–21
Elshikh MS, Hussein DS, Al-khattaf FS, El-Naggar RAR, Almaary KS (2022) Diclofenac removal from the wastewater using activated sludge and analysis of multidrug resistant bacteria from the sludge. Environ Res 208:112723
Fakhri H, Arabacı DN, Ünlü İD, Yangin-Gomec C, Ovez S, Aydin S (2021a) Addition of Trichocladium canadense to an anaerobic membrane bioreactor: evaluation of the microbial composition and reactor performance. Biofouling 37(7):711–723
Fakhri H, Shahi A, Ovez S, Aydin S (2021b) Bioaugmentation with immobilized endophytic penicillium restrictum to improve quorum quenching activity for biofouling control in an aerobic hollow-fiber membrane bioreactor treating antibiotic-containing wastewater. Ecotoxicol Environ Saf 210:111831
Fan N-S, Bai Y-H, Chen Q-Q, Shen Y-Y, Huang B-C, Jin R-C (2020) Deciphering the toxic effects of antibiotics on denitrification: process performance, microbial community and antibiotic resistance genes. J Environ Manag 262:110375
Fan Z, Yang S, Zhu Q, Zhu X (2022) Effects of different oxygen conditions on pollutants removal and the abundances of tetracycline resistance genes in activated sludge systems. Chemosphere 291:132681
Femina Carolin C, Senthil Kumar P, Janet Joshiba G, Vinoth Kumar V (2021) Analysis and removal of pharmaceutical residues from wastewater using membrane bioreactors: a review. Environ Chem Lett 19(1):329–343. https://doi.org/10.1007/s10311-020-01068-9
Ferreira AR, Guedes P, Mateus EP, Ribeiro AB, Couto N (2020) Emerging organic contaminants in soil irrigated with effluent: electrochemical technology as a remediation strategy. Sci Total Environ 743:140544
Ferrer-Polonio E, Fernández-Navarro J, Iborra-Clar M-I, Alcaina-Miranda M-I, Mendoza-Roca JA (2020) Removal of pharmaceutical compounds commonly-found in wastewater through a hybrid biological and adsorption process. J Environ Manage 263:110368
Forruque AS, Mofijur M, Nuzhat S, Chowdhury AT, Nazifa Rafa Md, Uddin A, Inayat A et al (2021) Recent developments in physical, biological, chemical, and hybrid treatment techniques for removing emerging contaminants from wastewater. J Hazard Mater 416:125912
Fu J, Zhang Q, Huang B, Fan N, Jin R (2020) A review on anammox process for the treatment of antibiotic-containing wastewater: linking effects with corresponding mechanisms. Front Environ Sci Eng 15(1):17
Galani A, Alygizakis N, Aalizadeh R, Kastritis E, Dimopoulos M-A, Thomaidis NS (2021) Patterns of pharmaceuticals use during the first wave of COVID-19 pandemic in Athens, Greece as revealed by wastewater-based epidemiology. Sci Total Environ 798:149014
García L, Leyva-Díaz JC, Díaz E, Ordóñez S (2021) A review of the adsorption-biological hybrid processes for the abatement of emerging pollutants: removal efficiencies, physicochemical analysis, and economic evaluation. Sci Total Environ 780:146554
García-Fernández AJ, Espín S, Gómez-Ramírez P, Sánchez-Virosta P, Navas I (2021) Water quality and contaminants of emerging concern (CECs). In: Chemometrics and cheminformatics in aquatic toxicology. Wiley, pp 1‑21
Gernigon C, Othenin J, Michaud A, Vayr F, Rousseau V, Montastier E, Lapeyre-Mestre M, Niezborala M, Hérin F (2020) Évaluation de la consommation médicamenteuse d’une population de travailleurs de la région Toulousaine en 2016. Archives Des Maladies Professionnelles Et De L’environnement 81(1):81
Ghahari S, Ghahari S, Ghahari S, Nematzadeh G, Sarma H (2021) Integrated remediation approaches for selected pharmaceutical and personal care products in urban soils for a sustainable future. Energy Ecol Environ 8:1–14
Giannakis S, Lin K-Y, Ghanbari F (2021) A review of the recent advances on the treatment of industrial wastewaters by sulfate radical-based advanced oxidation processes (SR-AOPs). Chem Eng J 406:127083
Gonzalez-Tineo PA, Durán-Hinojosa U, Delgadillo-Mirquez LR, Meza-Escalante ER, Gortáres-Moroyoqui P, Ulloa-Mercado RG, Serrano-Palacios D (2020) Performance improvement of an integrated anaerobic-aerobic hybrid reactor for the treatment of swine wastewater. J Water Process Eng 34:101164
Guan A, Qi W, Peng Q, Zhou J, Bai Y, Jiuhui Qu (2022) Environmental heterogeneity determines the response patterns of microbially mediated N-reduction processes to sulfamethoxazole in river sediments. J Hazard Mater 421:126730
Gulzar S, Gul S, Patra A, Mohapatra KK, Jatav HS, Rajput VD (2022) Socio economic aspects of sewage sludge use in agriculture. In: Rajput VD, Yadav AN, Jatav HS, Singh SK, Minkina T (eds) Sustainable management and utilization of sewage sludge. Springer, Cham, pp 281–296
Guo N, Ma X, Ren S, Wang S, Wang Y (2019) Mechanisms of metabolic performance enhancement during electrically assisted anaerobic treatment of chloramphenicol wastewater. Water Res 156:199–207
Guo K, Zihao W, Fang J (2020a) Chapter 10—UV-based advanced oxidation process for the treatment of pharmaceuticals and personal care products. In: Hernández-Maldonado AJ, Blaney L (eds) Contaminants of emerging concern in water and wastewater. Butterworth-Heinemann, pp 367–408
Guo W, Cheng D, Ngo HH, Chang SW, Nguyen DD, Nguyen DP, Bui XT (2020b) 9—Anaerobic membrane bioreactors for antibiotic wastewater treatment. In: Ngo HH, Guo W, Ng HY, Mannina G, Pandey A (eds) Current developments in biotechnology and bioengineering. Elsevier, pp 219–239
Guo J, Liu S, Zhou Li, Cheng Bo, Li Qi (2021) Prioritizing pharmaceuticals based on environmental risks in the aquatic environment in China. J Environ Manag 278:111479
Gupta R, Kumar S (2022) Intuitionistic fuzzy scale-invariant entropy with correlation coefficients-based VIKOR approach for multi-criteria decision-making. Granul Comput 7(1):77–93
Gurmessa B, Pedretti EF, Cocco S, Cardelli V, Corti G (2020) Manure anaerobic digestion effects and the role of pre- and post-treatments on veterinary antibiotics and antibiotic resistance genes removal efficiency. Sci Total Environ 721:137532
Hajji S, Alla AA, Noureddine S, Haddad MB, Moukrim A (2021) Study of physicochemical and bacteriological quality of treated wastewater by the New Aourir Plant (Southwestern of Morocco) using activated sludge technology in a Semi-Arid region. J Ecol Eng 22(6):83–98
Hammond EB, Coulon F, Hallett SH, Thomas R, Hardy D, Kingdon A, Beriro DJ (2021) A critical review of decision support systems for brownfield redevelopment. Sci Total Environ 785:147132
Han Y, Yang L, Xueming Chen Yu, Cai XZ, Qian M, Chen X et al (2020) Removal of veterinary antibiotics from swine wastewater using anaerobic and aerobic biodegradation. Sci Total Environ 709:136094
Harb M, Lou E, Smith AL, Stadler LB (2019) Perspectives on the fate of micropollutants in mainstream anaerobic wastewater treatment. Curr Opin Biotechnol Energy Biotechnol Environ Biotechnol 57:94–100
Harrower J, McNaughtan M, Hunter C, Hough R, Zhang Z, Helwig K (2021) Chemical fate and partitioning behavior of antibiotics in the aquatic environment—a review. Environ Toxicol Chem 40(12):3275–3298
Harshkova D, Majewska M, Pokora W, Baścik-Remisiewicz A, Tułodziecki S, Aksmann A (2021) Diclofenac and atrazine restrict the growth of a synchronous chlamydomonas reinhardtii population via various mechanisms. Aquat Toxicol 230:105698
Hawrylik E, Butarewicz A (2021) Influence of low-frequency ultrasound on the disintegration of coliform and fecal coliform bacteria. J Ecol Eng 22(9):192–197
Hdidou M, Necibi MC, Labille J, El Hajjaji S, Dhiba D, Chehbouni A, Roche N (2022) Potential use of constructed wetland systems for rural sanitation and wastewater reuse in agriculture in the moroccan context. Energies 15(1):156
He WC, Lin J, Bing Yu, Owens G, Chen Z (2021) Reducing the impact of antibiotics in wastewaters: increased removal of mitoxantrone from wastewater by biosynthesized manganese nanoparticles. J Clean Prod 293:126207
Hmaidi El, Abdellah AT, Manssouri I, Jaddi H, Ben-Daoud M, Kasse Z, El Ouali A, Essahlaoui A (2021) Assessment of the physicochemical water quality of the Moulouya river, Morocco, using the SEQ-Eau index. Environ Monit Assess 194(1):37
Hosseinpour S, Azimian-Kivi M, Jafarzadeh Y, Yegani R (2021) Pharmaceutical wastewater treatment using polypropylene membranes incorporated with carboxylated and PEG-grafted nanodiamond in membrane bioreactor (MBR). Water Environ J 35(4):1249–1259
Hu D, Min H, Wang H, Zhao Y, Cui Y, Pan Wu, Ge H et al (2020) Performance of an up-flow anaerobic bio-electrochemical system (UBES) for treating sulfamethoxazole (SMX) antibiotic wastewater. Biores Technol 305:123070
Hu K, Sarrà M, Caminal G (2021a) Comparison between two reactors using trametes versicolor for agricultural wastewater treatment under non-sterile condition in sequencing batch mode. J Environ Manag 293:112859
Hu Z, Cai J, Song Ge, Tian Y, Zhou M (2021b) Anodic oxidation of organic pollutants: anode fabrication, process hybrid and environmental applications. Curr Opin Electrochem 26:100659
Huang B, Wang HC, Cui D, Zhang B, Chen ZB, Wang AJ (2018) Treatment of pharmaceutical wastewater containing β-lactams antibiotics by a pilot-scale anaerobic membrane bioreactor (AnMBR). Chem Eng J 341:238–247
Hui M-Y, Tan L-H, Letchumanan V, He Y-W, Fang C-M, Chan K-G, Law J-F, Lee L-H (2021) The extremophilic actinobacteria: from microbes to medicine. Antibiotics 10(6):682
Huidobro-López B, López-Heras I, Alonso-Alonso C, Martínez-Hernández V, Nozal L, de Bustamante I (2022) Analytical method to monitor contaminants of emerging concern in water and soil samples from a non-conventional wastewater treatment system. J Chromatogr A 1671:463006
Hussain MM, Wang J, Bibi I, Shahid M, Niazi NK, Iqbal J, Mian IA et al (2021) Arsenic speciation and biotransformation pathways in the aquatic ecosystem: the significance of algae. J Hazard Mater 403:124027
Jaén-Gil A, Buttiglieri G, Benito A, Mir-Tutusaus JA, Gonzalez-Olmos R, Caminal G, Barceló D, Sarrà M, Rodriguez-Mozaz S (2021) Combining biological processes with UV/H2O2 for metoprolol and metoprolol acid removal in hospital wastewater. Chem Eng J 404:126482
Jagaba AH, Kutty SRM, Lawal IM, Abubakar S, Hassan I, Zubairu I, Umaru I et al (2021) Sequencing batch reactor technology for landfill leachate treatment: a state-of-the-art review. J Environ Manag 282:111946
Jain A, Sarsaiya S, Awasthi MK, Singh R, Rajput R, Mishra UC, Chen J, Shi J (2022) Bioenergy and bio-products from bio-waste and its associated modern circular economy: current research trends, challenges, and future outlooks. Fuel 307:121859
Jamil S, Loganathan P, Khan SJ, McDonald JA, Kandasamy J, Vigneswaran S (2021) Enhanced nanofiltration rejection of inorganic and organic compounds from a wastewater-reclamation plant’s micro-filtered water using adsorption pre-treatment. Sep Purif Technol 260:118207
Jhunjhunwala A, Pathak U, Sarkar KK, Majee S, Mandal DD, Mandal T (2021) Removal of levosulpiride from pharmaceutical wastewater using an advanced integrated treatment strategy comprising physical, chemical, and biological treatment. Environ Prog Sustain Energy 40(1):e13482
Jiang L, Li Y, Pei H (2021a) Algal-bacterial consortia for bioproduct generation and wastewater treatment. Renew Sustain Energy Rev 149:111395
Jiang X, Chen D, Yang Mu, Pant D, Cheng H, Shen J (2021b) Electricity-stimulated anaerobic system (ESAS) for enhanced energy recovery and pollutant removal: a critical review. Chem Eng J 411:128548
Jing YANG, Wei-Li L, Fu-Chuan H (2021) Review of SBR process in effluent treatment. In: E3S web of conferences, vol 233, p 01120
Joannis-Cassan C, Rodriguez AS, Castillo CD, Gómez-Canela C, Reoyo-Prats B, Calas-Blanchard C, Barata C, Lacorte S, Plantard G (2021) Towards an innovative combined process coupling biodegradation and photo-oxidation for the removal of pharmaceutical residues. J Chem Technol Biotechnol 96(3):755–763
Johansen MR, Christensen TB, Ramos TM, Syberg K (2022) A review of the plastic value chain from a circular economy perspective. J Environ Manag 302:113975
Jose J, Pinto JS, Kotian B, Thomas AM, Charyulu RN (2020) Comparison of the regulatory outline of ecopharmacovigilance of pharmaceuticals in Europe, USA, Japan and Australia. Sci Total Environ 709:134815
Juma A, Lemoine P, Simpson ABJ, Murray J, O’Hagan BMG, Naughton PJ, Dooley JG, Banat IM (2020) Microscopic investigation of the combined use of antibiotics and biosurfactants on methicillin resistant Staphylococcus aureus. Front Microbiol 11:1477
Kairigo P, Ngumba E, Sundberg L-R, Gachanja A, Tuhkanen T (2020) Occurrence of antibiotics and risk of antibiotic resistance evolution in selected kenyan wastewaters, surface waters and sediments. Sci Total Environ 720:137580
Kamali M, Costa ME, Aminabhavi TM, Capela I (2019a) Sustainability of treatment technologies for industrial biowastes effluents. Chem Eng J 370:1511–1521
Kamali M, Persson KM, Costa ME, Capela I (2019b) Sustainability criteria for assessing nanotechnology applicability in industrial wastewater treatment: current status and future outlook. Environ Int 125:261–276
Kamali M, Aminabhavi TM, Tarelho LAC, Hellemans R, Cuypers J, Capela I, Maria EV, Costa RD, Appels L (2022) Acclimatized activated sludge for enhanced phenolic wastewater treatment using pinewood biochar. Chem Eng J 427:131708
Kanafin YN, Kakimov Y, Adamov A, Makhatova A, Yeshmuratov A, Poulopoulos SG, Inglezakis VJ, Arkhangelsky E (2021a) The effect of caffeine, metronidazole, and ibuprofen on continuous flow activated sludge process. J Chem Technol Biotechnol 96(5):1370–1380
Kanafin YN, Kanafina D, Malamis S, Katsou E, Inglezakis VJ, Poulopoulos SG, Arkhangelsky E (2021b) Anaerobic membrane bioreactors for municipal wastewater treatment: a literature review. Membranes 11(12):967
Kanafin Y, Satayeva A, Arkhangelsky E, Poulopoulos S (2021c) Treatment of a biological effluent containing metronidazole. Chem Eng Trans 86:595–600
Kar S, Sanderson H, Roy K, Benfenati E, Leszczynski J (2020) Ecotoxicological assessment of pharmaceuticals and personal care products using predictive toxicology approaches. Green Chem 22(5):1458–1516
Karanan S, Rodmuang S, Kongkrashang P (2020) Treatment of municipal wastewater by anaerobic sequencing batch reactor with shoe soles. http://repository.rmutp.ac.th/handle/123456789/3381
Karim M, Ktit J, Soussi NO, Sobhi K (2021) Potential areas for investment in Morocco. An analysis using inputs-outputs model. Adv Manag Appl Econ 11(1):47–72
Katam K, Bhattacharyya D, Soda S, Shimizu T (2021) Effect of hydraulic retention time on the performance of trickling photo-bioreactor treating domestic wastewater: Removal of carbon, nutrients, and micropollutants. J Ind Eng Chem 102:351–362
Keerthanan S, Jayasinghe C, Biswas JK, Vithanage M (2021) Pharmaceutical and personal care products (PPCPs) in the environment: plant uptake, translocation, bioaccumulation, and human health risks. Crit Rev Environ Sci Technol 51(12):1221–1258
Khadir A, Mollahosseini A, Negarestani M, Mardy A (2020) Anaerobic biotechnology for the treatment of pharmaceutical compounds and hospital wastewaters. In: Inamuddin MIA, Lichtfouse E, Asiri AM (eds) Methods for bioremediation of water and wastewater pollution. Environmental chemistry for a sustainable world. Springer, Cham, pp 61–84
Khalil AME, Memon FA, Tabish TA, Salmon D, Zhang S, Butler D (2020) Nanostructured porous graphene for efficient removal of emerging contaminants (pharmaceuticals) from water. Chem Eng J 398:125440
Khan AA, Boddu S (2021) Chapter 13—Hybrid membrane process: an emerging and promising technique toward industrial wastewater treatment. In: Shah MP, Rodriguez-Couto S (eds) Membrane-based hybrid processes for wastewater treatment. Elsevier, pp 257–277
Khan NA, Ahmed S, Farooqi IH, Imran Ali V, Vambol FC, Yousefi M, Vambol S, Khan SU, Khan AH (2020a) Occurrence, sources and conventional treatment techniques for various antibiotics present in hospital wastewaters: a critical review. Trends Anal Chem 129:115921
Khan NA, Khan SU, Ahmed S, Farooqi IH, Yousefi M, Mohammadi AA, Changani F (2020b) Recent trends in disposal and treatment technologies of emerging-pollutants—a critical review. Trends Anal Chem 122:115744
Khan AH, Aziz HA, Khan NA, Hasan MA, Ahmed S, Farooqi IH, Dhingra A et al (2021a) Impact, disease outbreak and the eco-hazards associated with pharmaceutical residues: a critical review. Int J Environ Sci Technol 8:1–23
Khan MT, Shah IA, Ihsanullah Ihsanullah Mu, Naushad SA, Shah SHA, Mohammad AW (2021b) Hospital wastewater as a source of environmental contamination: an overview of management practices, environmental risks, and treatment processes. J Water Process Eng 41:101990
Khan NA, Khan AH, Tiwari P, Zubair M, Naushad Mu (2021c) New insights into the integrated application of fenton-based oxidation processes for the treatment of pharmaceutical wastewater. J Water Process Eng 44:102440
Khetrapal S, Bhatia R (2020) Impact of COVID-19 pandemic on health system & sustainable development goal 3. Indian J Med Res 151(5):395–399
Khoshvaght H, Delnavaz M, Leili M (2021) Optimization of acetaminophen removal from high load synthetic pharmaceutical wastewater by experimental and ANOVA analysis. J Water Process Eng 42:102107
Kim S, Nam S-N, Jang Am, Jang M, Park CM, Son A, Her N, Heo J, Yoon Y (2022) Review of adsorption-membrane hybrid systems for water and wastewater treatment. Chemosphere 286:131916
Kołecka K, Gajewska M, Stepnowski P, Caban M (2019) Spatial distribution of pharmaceuticals in conventional wastewater treatment plant with sludge treatment reed beds technology. Sci Total Environ 647:149–157
Kołecka K, Gajewska M, Cytawa S, Stepnowski P, Caban M (2020) Is sequential batch reactor an efficient technology to protect recipient against non-steroidal anti-inflammatory drugs and paracetamol in treated wastewater? Bioresour Technol 318:124068
Kong L, Shi X (2022) Effect of antibiotic mixtures on the characteristics of soluble microbial products and microbial communities in upflow anaerobic sludge blanket. Chemosphere 292:133531
Kong Q, Yang Y (2021) Recent advances in antibacterial agents. Bioorg Med Chem Lett 35:127799
Kong Z, Li Lu, Xue Yi, Yang M, Li Y-Y (2019) Challenges and prospects for the anaerobic treatment of chemical-industrial organic wastewater: a review. J Clean Prod 231:913–927
Koohathongsumrit N, Meethom W (2022) A fuzzy decision-making framework for route selection in multimodal transportation networks. Eng Manag J 4:1–16
Kortright KE, Chan BK, Koff JL, Turner PE (2019) Phage therapy: a renewed approach to combat antibiotic-resistant bacteria. Cell Host Microbe 25(2):219–232
Kovalakova P, Cizmas L, McDonald TJ, Marsalek B, Feng M, Sharma VK (2020) Occurrence and toxicity of antibiotics in the aquatic environment: a review. Chemosphere 251:126351
Kroon FJ, Berry KLE, Brinkman DL, Kookana R, Leusch FDL, Melvin SD, Neale PA et al (2020) Sources, presence and potential effects of contaminants of emerging concern in the marine environments of the great barrier Reef and Torres Strait, Australia. Sci Total Environ 719:135140
Kumar S, Kushwaha R, Kumar S, Verma ML (2022) Chapter 9—Decongestion of lignocellulosics: a critical assessment of physicochemical approaches. In: Sanjay S (ed) Handbook of biofuels. Academic Press, pp 189–206
Landecker H (2021) La résistance aux antibiotiques et la biologie de l’Histoire. Traduit par Lisa Blackman. Revue D’anthropologie Des Connaissances 15:15–23
Leiviskä T, Risteelä S (2022) Analysis of pharmaceuticals, hormones and bacterial communities in a municipal wastewater treatment plant—comparison of parallel full-scale membrane bioreactor and activated sludge systems. Environ Pollut 292:118433
Li S, Show PL, Ngo HH, Ho SH (2022) Algae-mediated antibiotic wastewater treatment: a critical review. Environ Sci Ecotechnol 16:100145
Liang J, Meng H, Zhou J, Yin Y, Zhen H, Zhao Y, Zhang K (2021) Simultaneous occurrence of psychotropic pharmaceuticals in surface water of the megacity shanghai and implication for their ecotoxicological risks. ACS ES&T Water 1(4):825–836
Lindberg RH, Namazkar S, Lage S, Östman M, Gojkovic Z, Funk C, Gentili FG, Tysklind M (2021) Fate of active pharmaceutical ingredients in a northern high-rate algal pond fed with municipal wastewater. Chemosphere 271:129763
Liu Y, Yang Y, Liu Y, Tzeng G-H (2019) Improving sustainable mobile health care promotion: a novel hybrid MCDM method. Sustainability 11(3):752
Liu Na, Jin X, Feng C, Wang Z, Fengchang Wu, Johnson AC, Xiao H, Hollert H, Giesy JP (2020a) Ecological risk assessment of fifty pharmaceuticals and personal care products (PPCPs) in Chinese surface waters: a proposed multiple-level system. Environ Int 136:105454
Liu X, Liang C, Liu X, Zhao F, Han C (2020b) Occurrence and human health risk assessment of pharmaceuticals and personal care products in real agricultural systems with long-term reclaimed wastewater irrigation in Beijing, China. Ecotoxicol Environ Saf 190:110022
Liu Y, Li X, Tan Z, Yang C (2021) Inhibition of tetracycline on anaerobic digestion of swine wastewater. Bioresour Technol 334:125253
Liu W, Song X, Na Z, Li G, Luo W (2022) Strategies to enhance micropollutant removal from wastewater by membrane bioreactors: recent advances and future perspectives. Bioresour Technol 344:126322
Lou EG, Harb M, Smith AL, Stadler LB (2020) Livestock manure improved antibiotic resistance gene removal during co-treatment of domestic wastewater in an anaerobic membrane bioreactor. Environ Sci Water Res Technol 6(10):2832–2842
Lu Z-Y, Ma Y-L, Zhang J-T, Fan N-S, Huang B-C, Jin R-C (2020) A critical review of antibiotic removal strategies: performance and mechanisms. J Water Process Eng 38:101681
Mahajan A, Binaz V, Singh I, Arora N (2022) Selection of natural fiber for sustainable composites using hybrid multi criteria decision making techniques. Compos Part C Open Access 7:100224
Majewska M, Harshkova D, Pokora W, Baścik-Remisiewicz A, Tułodziecki S, Aksmann A (2021) Does diclofenac act like a photosynthetic herbicide on green algae? Chlamydomonas Reinhardtii synchronous culture-based study with atrazine as reference. Ecotoxicol Environ Saf 208:111630
Makan A, Gouraizim M, Fadili A (2021) Sustainability assessment of wastewater treatment systems using cardinal weights and PROMETHEE method: case study of Morocco. Environ Sci Pollut Res 16:1–13
Mannina G, Rebouças TF, Cosenza A, Sànchez-Marrè M, Gibert K (2019) Decision support systems (DSS) for wastewater treatment plants—a review of the state of the art. Bioresour Technol 290:121814
Mansir I, Oertlé E, Choukr-Allah R (2021) Evaluation of the performance and quality of wastewater treated by M’zar Plant in Agadir, Morocco. Water 13(7):954
Mareai BM, Fayed M, Aly SA, Elbarki WI (2020) Performance comparison of phenol removal in pharmaceutical wastewater by activated sludge and extended aeration augmented with activated carbon. Alex Eng J 59(6):5187–5196
Martínez-Alcalá I, Guillén-Navarro JM, Lahora A (2021) Occurrence and fate of pharmaceuticals in a wastewater treatment plant from southeast of Spain and risk assessment. J Environ Manag 279:111565
Matsubara ME, Helwig K, Hunter C, Roberts J, Subtil EL, Coelho LHG (2020) Amoxicillin removal by pre-denitrification membrane bioreactor (A/O-MBR): performance evaluation, degradation by-products, and antibiotic resistant bacteria. Ecotoxicol Environ Saf 192:110258
Mojiri A, Zhou J, Vakili M, Van Le H (2020) Removal performance and optimisation of pharmaceutical micropollutants from synthetic domestic wastewater by hybrid treatment. J Contam Hydrol 235:103736
Mojiri A, Zhou JL, Ratnaweera H, Rezania S, Mansoureh NV (2022) Pharmaceuticals and personal care products in aquatic environments and their removal by algae-based systems. Chemosphere 288:132580
Molinari R, Lavorato C, Argurio P (2020) Application of hybrid membrane processes coupling separation and biological or chemical reaction in advanced wastewater treatment. Membranes 10(10):281
Monteoliva-García A, Martín-Pascual J, Muñío MM, Poyatos JM (2020) Effects of carrier addition on water quality and pharmaceutical removal capacity of a membrane bioreactor—advanced oxidation process combined treatment. Sci Total Environ 708:135104
Mousel D, Bastian D, Firk J, Palmowski L, Pinnekamp J (2021) Removal of pharmaceuticals from wastewater of health care facilities. Sci Total Environ 751:141310
Moya-Llamas MJ, Trapote A, Prats D (2021) Carbamazepine removal from low-strength municipal wastewater using a combined UASB-MBR treatment system. Water Sci Technol 83(8):1920–1931
Mukherjee A, Mullick A, Moulik S, Roy A (2021) Oxidative degradation of emerging micropollutants induced by rotational hydrodynamic cavitating device: a case study with ciprofloxacin. J Environ Chem Eng 9(4):105652
Mukimin A, Vistanty H, Zen N (2020) Hybrid advanced oxidation process (HAOP) as highly efficient and powerful treatment for complete demineralization of antibiotics. Sep Purif Technol 241:116728
Nagda A, Meena M, Shah MP (2021) Bioremediation of industrial effluents: a synergistic approach. J Basic Microbiol 62(3–4):395–414
Nguyen PY, Carvalho G, Maria AM (2021) A review of the biotransformations of priority pharmaceuticals in biological wastewater treatment processes. Water Res 188:116446
Nidheesh PV, Couras C, Karim AV, Nadais H (2021) A review of integrated advanced oxidation processes and biological processes for organic pollutant removal. Chem Eng Commun 1:1–43
Niemi L, Taggart M, Boyd K, Zhang Z, Gaffney PPJ, Pfleger S, Gibb S (2020) Assessing hospital impact on pharmaceutical levels in a rural ‘source-to-sink’ water system. Sci Total Environ 737:139618
Nozhevnikova AN, Russkova YuI, Litti YuV, Parshina SN, Zhuravleva EA, Nikitina AA (2020) Syntrophy and interspecies electron transfer in methanogenic microbial communities. Microbiology 89(2):129–147
Nys G (2021) Revue bibliographique des antibiorésistances portées par les entérobactéries isolées de reptiles et évaluation du profil de résistance d’ Escherichia coli isolées de reptiles en Belgique
Oertlé E, Mueller SR, Choukr-Allah R, Jaouani A (2020) Decision support tool for water reclamation beyond technical considerations—Egyptian, Moroccan, and Tunisian case studies. Integr Environ Assess Manag 16(6):885–897
Ogwueleka TC, Samson B (2020) The effect of hydraulic retention time on microalgae-based activated sludge process for Wupa Sewage Treatment Plant, Nigeria. Environ Monit Assess 192(5):271
Oliveira JFD, Fia R, Fia FRL, Rodrigues FN, Matos MPD (2020) Principal component analysis as a criterion for monitoring variable organic load of swine wastewater in integrated biological reactors UASB, SABF and HSSF-CW. J Environ Manag 262:110386–110386
Olvera-Vargas H, Gore-Datar N, Garcia-Rodriguez O, Mutnuri S, Lefebvre O (2021) Electro-fenton treatment of real pharmaceutical wastewater paired with a BDD anode: reaction mechanisms and respective contribution of homogeneous and heterogeneous OH. Chem Eng J 404:126524
Ooi GTH, Tang K, Chhetri RK, Kaarsholm KMS, Sundmark K, Kragelund C, Litty K et al (2018) Biological removal of pharmaceuticals from hospital wastewater in a pilot-scale staged moving bed biofilm reactor (MBBR) utilising nitrifying and denitrifying processes. Bioresour Technol 267:677–687
Ortiz-Marin AD, Amabilis-Sosa LE, Bandala ER, Guillén-Garcés RA, Treviño-Quintanilla LG, Roé-Sosa A, Moeller-Chávez GE (2020) Using sequentially coupled UV/H2O2-biologic systems to treat industrial wastewater with high carbon and nitrogen contents. Process Saf Environ Prot 137:192–199
Osińska A, Korzeniewska E, Harnisz M, Felis E, Bajkacz S, Jachimowicz P, Niestępski S, Konopka I (2020) Small-scale wastewater treatment plants as a source of the dissemination of antibiotic resistance genes in the aquatic environment. J Hazard Mater 381:121221
Ouakkas S, Arhouni FE, Hakkar M, Abdo MAS, Boukhair A, Essedaoui A, Benjelloun M (2022) Assessment of physicochemical and metallic contamination (Cd, Zn, Cu) and 222Rn activity in waters of the Doukkala Region, Morocco. J Hazard Toxic Radioact Waste 26(1):04021048
Oualkacha L, Stour L, Agoumi A (2022) Mainstreaming climate change adaptation into water development plan case of Morocco. In: Walter LF, Manolas E (eds) Climate change in the mediterranean and middle eastern region. Gestion, changement climatique. Springer, Cham, pp 345–363
Palma P, Fialho S, Lima A, Novais MH, Costa MJ, Montemurro N, Pérez S, Lopez M (2020) Pharmaceuticals in a mediterranean basin: the influence of temporal and hydrological patterns in environmental risk assessment. Sci Total Environ 709:136205
Pan M, Lyu T, Zhan L, Matamoros V, Angelidaki I, Cooper M, Pan G (2021) Mitigating antibiotic pollution using cyanobacteria: removal efficiency, pathways and metabolism. Water Res 190:116735
Pandis PK, Kalogirou C, Kanellou E, Vaitsis C, Savvidou MG, Sourkouni G, Zorpas AA, Argirusis C (2022) Key points of advanced oxidation processes (AOPs) for wastewater, organic pollutants and pharmaceutical waste treatment: a mini review. Chem Eng 6(1):8
Parhizgarsharif A, Lork A, Telvari A (2019) A hybrid approach based on the BWM-VIKOR and GRA for ranking facility location in construction site layout for Mehr project in Tehran. Decis Sci Lett 8(3):233–248
Park S, Oh S (2020) Detoxification and bioaugmentation potential for acetaminophen and its derivatives using Ensifer sp. isolated from activated sludge. Chemosphere 260:127532
Paśmionka IB, Bulski K, Herbut P, Boligłowa E, Frederico MC, Vieira GB, Prá MCD, Bortoli M (2021) Evaluation of the effectiveness of the activated sludge process in the elimination both ATB-resistant and ATB-susceptible E. coli strains. Energies 14(18):5868
Peña G, Israel O, Zavala MÁL, Ruelas HC (2021) Pharmaceuticals market, consumption trends and disease incidence are not driving the pharmaceutical research on water and wastewater. Int J Environ Res Public Health 18(5):2532
Pereira A, Silva L, Laranjeiro C, Lino C, Pena A (2020) Selected pharmaceuticals in different aquatic compartments: part i—source, fate and occurrence. Molecules 25(5):1026
Pilli S, Sellamuthu B, Pandey AK, Tyagi RD (2020) 13—Treatment of wastewater containing pharmaceuticals: biological treatment. In: Tyagi RD, Sellamuthu B, Tiwari B, Yan S, Drogui P, Zhang X, Pandey A (eds) Current developments in biotechnology and bioengineering. Elsevier, pp 463–520
Pirsaheb M, Mohamadisorkali H, Hossaini H, Hossini H, Makhdoumi P (2020) The hybrid system successfully to consisting of activated sludge and biofilter process from hospital wastewater: ecotoxicological study. J Environ Manage 276:111098
Piwowar A, Harasym J (2020) The importance and prospects of the use of algae in agribusiness. Sustainability 12(14):5669
Polianciuc SI, Gurzău AE, Kiss B, Ştefan MG, Loghin F (2020) Antibiotics in the environment: causes and consequences. Med Pharm Rep 93(3):231–240
Porika M, Ranjit P, Tippani R, Reddy KV (2021) Advances in the bioremediation of pharmaceuticals and personal care products (PPCPs): polluted water and soil. In: Pankaj Kumar A (ed) Microbial products for health, environment and agriculture microorganisms for sustainability. Springer, Singapore, pp 323–358
Pouya P, Khayati A, Chatouane K (2021) Growth sectors in morocco and investment potential: a quantitative analysis. Int J Econ Financ 13(10):1–54
Priyanka MS, Mohapatra S, Menon NG (2021) Chapter 23—Hybrid membrane technology: an alternative to industrial wastewater treatment. In: Shah MP, Rodriguez-Couto S (eds) Membrane-based hybrid processes for wastewater treatment. Elsevier, pp 481–501
Pugazhendi A, Jamal MT, Al-Mur BA, Jeyakumar RB (2022) Bioaugmentation of electrogenic halophiles in the treatment of pharmaceutical industrial wastewater and energy production in microbial fuel cell under saline condition. Chemosphere 288:132515
Qiu G, Chen H, Raghavan DSS, Ting Y-P (2021) Removal behaviors of antibiotics in a hybrid microfiltration-forward osmotic membrane bioreactor for real municipal wastewater treatment. Chem Eng J 417:129146
Quintelas C, Mesquita DP, Torres AM, Costa I, Ferreira EC (2020) Degradation of widespread pharmaceuticals by activated sludge: kinetic study, toxicity assessment, and comparison with adsorption processes. J Water Process Eng 33:101061
Rasheed T, Bilal M, Hassan AA, Nabeel F, Bharagava RN, Ferreira LFR, Tran HN, Hafiz MN (2020) Environmental threatening concern and efficient removal of pharmaceutically active compounds using metal-organic frameworks as adsorbents. Environ Res 185:109436
Rathi BS, Senthil Kumar P (2021) Application of adsorption process for effective removal of emerging contaminants from water and wastewater. Environ Pollut 280:116995
Reichert G, Mizukawa A, Antonelli J, de Almeida Brehm Goulart F, Filippe TC, Rodrigues de Azevedo JC (2020) Determination of parabens, triclosan, and lipid regulators in a subtropical urban river: effects of urban occupation. Water Air Soil Pollut 231:1–11
Ricky R, Shanthakumar S (2022) Phycoremediation integrated approach for the removal of pharmaceuticals and personal care products from wastewater—a review. J Environ Manage 302:113998
Rico A, de Oliveira R, de Souza Nunes GS, Rizzi C, Villa S, López-Heras I, Waichman AV (2021) Pharmaceuticals and other urban contaminants threaten amazonian freshwater ecosystems. Environ Int 155:106702
Rios-Miguel AB, Jetten MS, Welte CU (2021) Effect of concentration and hydraulic reaction time on the removal of pharmaceutical compounds in a membrane bioreactor inoculated with activated sludge. Microbial Biotechnol 14(4):1707–1721
Robson SV, Rosi EJ, Richmond EK, Grace MR (2020) Environmental concentrations of pharmaceuticals alter metabolism, denitrification, and diatom assemblages in artificial streams. Freshw Sci 39(2):256–267
Rorke DC, Lekha P, Kana GE, Sithole BB (2022) Effect of pharmaceutical wastewater as nitrogen source on the optimization of simultaneous saccharification and fermentation hydrogen production from paper mill sludge. Sustain Chem Pharm 25:100619
Rostam AB, Taghizadeh M (2020) Advanced oxidation processes integrated by membrane reactors and bioreactors for various wastewater treatments: a critical review. J Environ Chem Eng 8(6):104566
Rueda-Márquez JJ, Palacios-Villarreal C, Manzano M, Blanco E, del Solar MR, Levchuk I (2020) Photocatalytic degradation of pharmaceutically active compounds (PhACs) in urban wastewater treatment plants effluents under controlled and natural solar irradiation using immobilized TiO2. Sol Energy 208:480–492
Saghafi S, Ebrahimi A, Mehrdadi N, Bidhendy GN (2019) Evaluation of aerobic/anaerobic industrial wastewater treatment processes: the application of multi-criteria decision analysis. Environ Prog Sustain Energy 38(5):13166
Sahani S, Sharma YC, Kim TY (2022) Emerging contaminants in wastewater and surface water. In: Singh SP, Kumar A, Gupta T (eds) New trends in emerging environmental contaminants. Énergie, l’environnement et La Durabilité. Springer, Singapore, pp 9–30
Saidulu D, Gupta B, Gupta AK, Ghosal PS (2021) A review on occurrences, eco-toxic effects, and remediation of emerging contaminants from wastewater: special emphasis on biological treatment based hybrid systems. J Environ Chem Eng 9(4):105282
Sakurai KS, Ito CM, Pompei E, Tomita IN, Santos-Neto ÁJ, Silva GHR (2021) Hybrid constructed wetlands as post-treatment of blackwater: an assessment of the removal of antibiotics. J Environ Manag 278:111552
Salamirad A, Kheybari S, Ishizaka A, Farazmand H (2021) Wastewater treatment technology selection using a hybrid multicriteria decision-making method. Int Trans Oper Res 30(3):1479–1504
Salazar H, Martins PM, Santos B, Fernandes MM, Reizabal A, Sebastián V, Lanceros-Mendez S (2020) Photocatalytic and antimicrobial multifunctional nanocomposite membranes for emerging pollutants water treatment applications. Chemosphere 250:126299
Samal K, Bandyopadhyay R, Dash RR (2022) Biological treatment of contaminants of emerging concern in wastewater: a review. J Hazard Toxic Radioact Waste 26(2):04022002
Samoraj M, Mironiuk M, Izydorczyk G, Witek-Krowiak A, Szopa D, Moustakas K, Chojnacka K (2022) The challenges and perspectives for anaerobic digestion of animal waste and fertilizer application of the digestate. Chemosphere 295:133799
Santos A, Veiga F, Figueiras A (2020) Dendrimers as pharmaceutical excipients: synthesis, properties, toxicity and biomedical applications. Materials 13(1):65
Schwaller C, Hoffmann G, Hiller CX, Helmreich B, Drewes JE (2021) Inline dosing of powdered activated carbon and coagulant prior to ultrafiltration at pilot-scale—effects on trace organic chemical removal and operational stability. Chem Eng J 414:128801
Schwartz H, Marushka L, Chan HM, Batal M, Sadik T, Ing A, Fediuk K, Tikhonov C (2021) Pharmaceuticals in source waters of 95 first nations in Canada. Can J Public Health 112(1):133–153
Sengar A, Vijayanandan A (2022) Effects of pharmaceuticals on membrane bioreactor: review on membrane fouling mechanisms and fouling control strategies. Sci Total Environ 808:152132
Sevda S, Garlapati VK, Naha S, Sharma M, Ray SG, Sreekrishnan TR, Goswami P (2020) Biosensing capabilities of bioelectrochemical systems towards sustainable water streams: technological implications and future prospects. J Biosci Bioeng 129(6):647–656
Shah A, Shah M (2020) Characterisation and bioremediation of wastewater: a review exploring bioremediation as a sustainable technique for pharmaceutical wastewater. Groundw Sustain Dev 11:100383
Shahriar A, Tan J, Sharma P, Hanigan D, Verburg P, Pagilla K, Yang Yu (2021) Modeling the fate and human health impacts of pharmaceuticals and personal care products in reclaimed wastewater irrigation for agriculture. Environ Pollut 276:116532
Shi X, Leong KY, Ng HY (2017) Anaerobic treatment of pharmaceutical wastewater: a critical review. Biores Technol 245:1238–1244
Shokoohi R, Ghobadi N, Godini K, Hadi M, Atashzaban Z (2020) Antibiotic detection in a hospital wastewater and comparison of their removal rate by activated sludge and earthworm-based vermifilteration: environmental risk assessment. Process Saf Environ Prot 134:169–177
Shu Y, Liang D (2022) Effect of tetracycline on nitrogen removal in moving bed biofilm reactor (MBBR) system. PLoS ONE 17(1):e0261306
Sicard M, Crauste-Manciet S, Dole F, Verget J, Thiéry A, Barthélémy P (2020) Decontamination of organic pollutants from aqueous media using polymer-free bioinspired materials. ACS Sustain Chem Eng 8(30):11052–11057
Simon M, Kumar A, Garg A (2021) Biological treatment of pharmaceuticals and personal care products (PPCPs) before discharging to environment. In: Kumar P, Bharagava GRM (eds) Fate and transport of subsurface pollutants. Microorganisms for sustainability. Springer, Singapore, pp 259–282
Slamini M, Sbaa M, Arabi M, Darmous A, Bouknana D (2022) Citrus yield response and irrigation water use efficiency under partial root drying irrigation in a pilot exploitation in the Triffa plain (Eastern Morocco). Ecol Eng Environ Technol 23(1):178–191
Song Zi, Zhang X, Sun F, Ngo HH, Guo W, Wen H, Li C, Zhang Z (2020) Specific microbial diversity and functional gene (AOB AmoA) analysis of a sponge-based aerobic nitrifying moving bed biofilm reactor exposed to typical pharmaceuticals. Sci Total Environ 742:140660
Song J, Hanyang Wu, Yuan H, Jiang Wu, Qi W, Jianbo Lu, Li W, Li Y-Y (2022) Reclamation of pharmaceutical wastewater by UAF, contact oxidation, and auto brush-cleaning aiding nano ZrO2 coated ceramic membrane MBR—an industrial-scale practice and functional microbial diversity. J Water Process Eng 46:102563
Stévenne C, Micha M, Plumier JC, Roberty S (2021) Corals and sponges under the light of the holobiont concept: how microbiomes underpin our understanding of marine ecosystems. Front Mar Sci 8:1035
Sun J, Li N, Yang P, Zhang Y, Yuan Y, Xingwen Lu, Zhang H (2020a) Simultaneous antibiotic degradation, nitrogen removal and power generation in a microalgae-bacteria powered biofuel cell designed for aquaculture wastewater treatment and energy recovery. Int J Hydrogen Energy 45(18):10871–10881
Sun S, Yao H, Wanyi Fu, Xue S, Zhang W (2020b) Enhanced degradation of antibiotics by photo-fenton reactive membrane filtration. J Hazard Mater 386:121955
Sun M, Zhang Z, Liu G, Lv M, Feng Y (2021) Enhancing methane production of synthetic brewery water with granular activated carbon modified with nanoscale zero-valent Iron (NZVI) in anaerobic system. Sci Total Environ 760:143933
Swathi D, Sabumon PC, Trivedi A (2021) Simultaneous decolorization and mineralization of high concentrations of methyl orange in an anoxic up-flow packed bed reactor in denitrifying conditions. J Water Process Eng 40:101813
Szymańska U, Wiergowski M, Sołtyszewski I, Kuzemko J, Wiergowska G, Woźniak MK (2019) Presence of Antibiotics in the aquatic environment in Europe and their analytical monitoring: recent trends and perspectives. Microchem J 147:729–740
Tao Yu, Ersahin ME, Ghasimi DSM, Ozgun H, Wang H, Zhang X, Guo M, Yang Y, Stuckey DC, van Lier JB (2020) Biogas productivity of anaerobic digestion process is governed by a core bacterial microbiota. Chem Eng J 380:122425
Taoufik N, Boumya W, Achak M, Sillanpää M, Barka N (2021) Comparative overview of advanced oxidation processes and biological approaches for the removal pharmaceuticals. J Environ Manag 288:112404
Tiwari B, Drogui P, Tyagi RD (2020) Chapter 18—Removal of emerging micro-pollutants from pharmaceutical industry wastewater. In: Sunita V, Pandey A, Tyagi RD, Ngo HH, Larroche C (eds) Current developments in biotechnology and bioengineering. Elsevier, pp 457–480
Top S, Akgün M, Kıpçak E, Bilgili MS (2020) Treatment of hospital wastewater by supercritical water oxidation process. Water Res 185:116279
Tosun J, Schaub S, Fleig A (2020) What determines regulatory preferences? Insights from micropollutants in surface waters. Environ Sci Policy 106:136–144
Touzani I, Machkor M, Boudouch O, El Machrafi I, Flouchi R, Fikri-Benbrahim K (2020) Environmental impact assessment of Taza City’s wastewater: application through principal component analysis. Scientifica 2020:e9168569
Trouillard A, Sabri A, Prot-Labarthe S, Storme T, Bourrat E, Soulairol I (2022) Exposition pédiatrique aux perturbateurs endocriniens et substances cancérogčnes, mutagčnes ou reprotoxiques par des formes pharmaceutiques destinées ā la voie cutanée: dispositions réglementaires en France, en Europe, et état de l’art des connaissances scientifiques. Ann Pharmaceut Franįais 80(4):426–439
Ullah A, Hussain S, Wasim A, Jahanzaib M (2020) Development of a decision support system for the selection of wastewater treatment technologies. Sci Total Environ 731:139158
Upadhyay A, Pareek N, Vivekanand V (2022) Characteristics, parameters, and process design of anaerobic digesters. In: Biomethane. Apple Academic Press, pp 13–42
Usman M, Balsalobre-Lorente D (2022) Environmental concern in the era of industrialization: can financial development, renewable energy and natural resources alleviate some load? Energy Policy 162:112780
Usman M, Farooq M, Hanna K (2020) Environmental side effects of the injudicious use of antimicrobials in the era of COVID-19. Sci Total Environ 745:141053
Van D-A, Ngo TH, Huynh TH, Nakada N, Ballesteros F, Tanaka H (2021) Distribution of pharmaceutical and personal care products (PPCPs) in aquatic environment in hanoi and metro Manila. Environ Monit Assess 193(12):847
Vargas-Berrones K, Bernal-Jácome L, de León-Martínez LD, Flores-Ramírez R (2020) Emerging pollutants (EPs) in Latin América: a critical review of under-studied EPs, case of study-nonylphenol. Sci Total Environ 726:138493
Varnai P, Davé A, Farla K, Nooijen A, Petrosova L (2021) The evidence REVEAL study: exploring the use of real-world evidence and complex clinical trial design by the european pharmaceutical industry. Clin Pharmacol Ther 110(5):1180–1189
Vasilachi IC, Asiminicesei DM, Fertu DI, Gavrilescu M (2021) Occurrence and fate of emerging pollutants in water environment and options for their removal. Water 13(2):181
Vass P, Szabó E, Domokos A, Hirsch E, Galata D, Farkas B, Démuth B et al (2020) Scale-up of electrospinning technology: applications in the pharmaceutical industry. Wires Nanomed Nanobiotechnol 12(4):e1611
Vassalle L, García-Galán MJ, Aquino SF, Afonso RJDCF, Ferrer I, Passos F, Mota CR (2020) Can high rate algal ponds be used as post-treatment of UASB reactors to remove micropollutants? Chemosphere 248:125969
Velasco-Garduño O, González-Blanco G, Fajardo-Ortiz MDC, Beristain-Cardoso R (2021) Influence of metronidazole on activated sludge activity. Environ Technol 42(18):2815–2822
Verma M, Haritash AK (2020) Review of advanced oxidation processes (AOPs) for treatment of pharmaceutical wastewater. Adv Environ Res 9(1):1–17
Viegas RMC, Mestre AS, Mesquita E, Campinas M, Andrade MA, Carvalho AP, Rosa MJ (2020) Assessing the applicability of a new carob waste-derived powdered activated carbon to control pharmaceutical compounds in wastewater treatment. Sci Total Environ 743:140791
Villemin C, Abel F, Dispersyn G, Cotty-Eslous M, Marchand S (2021) La réalité virtuelle comme antidouleur: une revue systématique de la littérature. Douleur Et Analgésie 34(3):163–170
Vistanty H, Crisnaningtyas F (2021) Integration of upflow anaerobic sludge blanket and constructed wetlands for pharmaceutical wastewater treatment. IOP Conf Ser Earth Environ Sci 623(1):012082
Wang J, Chen X (2022) Removal of antibiotic resistance genes (ARGs) in various wastewater treatment processes: an overview. Crit Rev Environ Sci Technol 52(4):571–630
Wang J, Zhuan R (2020) Degradation of antibiotics by advanced oxidation processes: an overview. Sci Total Environ 701:135023
Wang D, Li Y, Zhuang H, Yi X, Yang F, Han H (2019) Direct current triggering enhanced anaerobic treatment of acetyl pyrimidine-containing wastewater in up-flow anaerobic sludge blanket coupled with bioelectrocatalytic system. Chemosphere 231:457–467
Wang J, Chu L, Wojnárovits L, Takács E (2020a) Occurrence and fate of antibiotics, antibiotic resistant genes (ARGs) and antibiotic resistant bacteria (ARB) in municipal wastewater treatment plant: an overview. Sci Total Environ 744:140997
Wang S, Ma X, Liu Y, Yi X, Guocheng Du, Li Ji (2020b) Fate of antibiotics, antibiotic-resistant bacteria, and cell-free antibiotic-resistant genes in full-scale membrane bioreactor wastewater treatment plants. Biores Technol 302:122825
Wang H, Xi H, Linling Xu, Jin M, Zhao W, Liu H (2021a) Ecotoxicological effects, environmental fate and risks of pharmaceutical and personal care products in the water environment: a review. Sci Total Environ 788:147819
Wang M, Chen H, Liu S, Xiao L (2021b) Removal of pathogen and antibiotic resistance genes from waste activated sludge by different pre-treatment approaches. Sci Total Environ 763:143014
Wang R, Li C, Lv N, Pan X, Cai G, Ning J, Zhu G (2021c) Deeper insights into effect of activated carbon and nano-zero-valent iron addition on acidogenesis and whole anaerobic digestion. Biores Technol 324:124671
Wang C, Liu J, Li Q, Huang Li, Wang C, Kai Wu, Zhao X, Yin F, Liang C, Zhang W (2022) A review of the effects of antibiotics on the anaerobic digestion of swine waste. Curr Opin Environ Sci Health 25:100312
Webb SF (2001) A data-based perspective on the environmental risk assessment of human pharmaceuticals I—collation of available ecotoxicity data. In: Klaus K (ed) Pharmaceuticals in the environment: sources, fate, effects and risks. Springer, Berlin, pp 175–201
Xiao L, Wang Y, Lichtfouse E, Zhenkai Li P, Kumar S, Liu J, Feng D, Yang Q, Liu F (2021) Effect of antibiotics on the microbial efficiency of anaerobic digestion of wastewater: a review. Front Microbiol 11:611613
Xie S, Li X, Wang C, Kulandaivelu J, Jiang G (2020) Enhanced anaerobic digestion of primary sludge with additives: performance and mechanisms. Biores Technol 316:123970
Xu R, Zhiyong Wu, Zhou Z, Meng F (2019a) Removal of sulfadiazine and tetracycline in membrane bioreactors: linking pathway to microbial community shift. Environ Technol 40(2):134–143
Xu Z, Song X, Li Y, Li G, Luo W (2019b) Removal of antibiotics by sequencing-batch membrane bioreactor for swine wastewater treatment. Sci Total Environ 684:23–30
Xu L, Yang L, Guo S, Zhou J, Luo T, Ran Yi, Li J, Long E, Mei Z, Huang R (2021) Experimental and CFD simulation study on anaerobic digestion using dextran pharmaceutical wastewater based on cyclic fluidization hydraulic mixing. Environ Prog Sustain Energy 40(5):e13656
Yadav B, Pandey AK, Kumar LR, Kaur R, Yellapu SK, Sellamuthu B, Drogui P (2020) 1—Introduction to wastewater microbiology: special emphasis on hospital wastewater. In: Tyagi RD, Sellamuthu B, Tiwari B, Yan S, Drogui P, Zhang X, Pandey A (eds) Current developments in biotechnology and bioengineering. Elsevier, pp 1–41
Yang Y, Wang L, Xiang F, Zhao L, Qiao Z (2020) Activated sludge microbial community and treatment performance of wastewater treatment plants in industrial and municipal zones. Int J Environ Res Public Health 17(2):436
Yenkie KM (2019) Integrating the three E’s in wastewater treatment: efficient design, economic viability, and environmental sustainability. Curr Opin Chem Eng 26:131–138
Yildiz T, Günay ŞKS (2021) Chapter 24—Developments in membrane bioreactor technologies and evaluation on case study applications for recycle and reuse of miscellaneous wastewaters. In: Susana Rodriguez-Couto MPS (ed) Membrane-based hybrid processes for wastewater treatment. Elsevier, pp 503–575
Zahedi S, Gros M, Casabella O, Petrovic M, Balcazar JL, Pijuan M (2022) Occurrence of veterinary drugs and resistance genes during anaerobic digestion of poultry and cattle manures. Sci Total Environ 822:153477
Zainab SM, Junaid M, Nan Xu, Malik RN (2020) Antibiotics and antibiotic resistant genes (ARGs) in groundwater: a global review on dissemination, sources, interactions, environmental and human health risks. Water Res 187:116455
Zamri MFMA, Bahru R, Pramanik SK, Fattah IMR (2021) Treatment strategies for enhancing the removal of endocrine-disrupting chemicals in water and wastewater systems. J Water Process Eng 41:102017
Zarei-Baygi A, Harb M, Wang P, Stadler LB, Smith AL (2020) Microbial community and antibiotic resistance profiles of biomass and effluent are distinctly affected by antibiotic addition to an anaerobic membrane bioreactor. Environ Sci Water Res Technol 6(3):724–736
Zhang C, Dong S, Chen C, Zhang Q, Zhou D (2020a) Co-substrate addition accelerated amoxicillin degradation and detoxification by up-regulating degradation related enzymes and promoting cell resistance. J Hazard Mater 394:122574
Zhang H, Yuan X, Wang H, Ma S, Ji B (2020b) Performance and microbial community of different biofilm membrane bioreactors treating antibiotic-containing synthetic mariculture wastewater. Membranes 10(10):282
Zhang C, Zhao Z, Dong S, Zhou D (2021) Simultaneous elimination of amoxicillin and antibiotic resistance genes in activated sludge process: contributions of easy-to-biodegrade food. Sci Total Environ 764:142907
Zhang R, Xuming Xu, Jia D, Lyu Y, Jingrun Hu, Chen Q, Sun W (2022) Sediments alleviate the inhibition effects of antibiotics on denitrification: functional gene, microbial community, and antibiotic resistance gene analysis. Sci Total Environ 804:150092
Zhao Y, Zhuang X, Ahmad S, Sung S, Ni S-Q (2020) Biotreatment of high-salinity wastewater: current methods and future directions. World J Microbiol Biotechnol 36(3):37
Zhou J, Ding J, Wan H, Guan G (2021) Boosting photocatalytic degradation of antibiotic wastewater by synergy effect of heterojunction and phosphorus doping. J Colloid Interface Sci 582:961–968
Zhu T-T, Zhong-xian Su, Lai W-X, Zhang Y-B, Liu Y-W (2021) Insights into the fate and removal of antibiotics and antibiotic resistance genes using biological wastewater treatment technology. Sci Total Environ 776:145906
Funding
Not applicable.
Author information
Authors and Affiliations
Contributions
AI, AM, AP, YK, and LM tested and analyzed the data. AI, AA, and SS interpreted the data and contributed to writing the paper.
Corresponding author
Ethics declarations
Conflict of interest
The authors declare no competing interests.
Ethics approval and consent to participate
Not applicable.
Consent for publication
Not applicable.
Additional information
Editorial responsibility: Samareh Mirkia.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
khalidi-idrissi, A., Madinzi, A., Anouzla, A. et al. Recent advances in the biological treatment of wastewater rich in emerging pollutants produced by pharmaceutical industrial discharges. Int. J. Environ. Sci. Technol. 20, 11719–11740 (2023). https://doi.org/10.1007/s13762-023-04867-z
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13762-023-04867-z